Movatterモバイル変換


[0]ホーム

URL:


USD1033637S1 - Fluid exchange device - Google Patents

Fluid exchange device
Download PDF

Info

Publication number
USD1033637S1
USD1033637S1US29/824,354US202229824354FUSD1033637SUS D1033637 S1USD1033637 S1US D1033637S1US 202229824354 FUS202229824354 FUS 202229824354FUS D1033637 SUSD1033637 SUS D1033637S
Authority
US
United States
Prior art keywords
exchange device
fluid exchange
view
fluid
ornamental design
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/824,354
Inventor
Joshua David Horvath
Kristof Hovaten
Daniel Douglass
Keith Bianchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
ForSight Vision4 Inc
Phillips Medisize LLC
Original Assignee
ForSight Vision4 Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US29/824,354priorityCriticalpatent/USD1033637S1/en
Application filed by ForSight Vision4 IncfiledCriticalForSight Vision4 Inc
Priority to TW112301576Fprioritypatent/TWD227106S/en
Priority to JP2022015578Fprioritypatent/JP1739057S/en
Priority to TW112301574Fprioritypatent/TWD227104S/en
Priority to JP2023008514Fprioritypatent/JP1747386S/en
Priority to TW112301571Fprioritypatent/TWD227102S/en
Priority to TW112301573Fprioritypatent/TWD227103S/en
Priority to JP2023000956Fprioritypatent/JP1747368S/en
Priority to JP2023008515Fprioritypatent/JP1747387S/en
Priority to JP2023008518Fprioritypatent/JP1747388S/en
Priority to TW111303604Fprioritypatent/TWD226875S/en
Priority to JP2023008513Fprioritypatent/JP1747385S/en
Priority to TW112301575Fprioritypatent/TWD227105S/en
Priority to JP2023008516Fprioritypatent/JP1751600S/en
Priority to TW112301572Fprioritypatent/TWD226850S/en
Priority to CA214446Fprioritypatent/CA214446S/en
Priority to CA229752Fprioritypatent/CA229752S/en
Priority to CA229754Fprioritypatent/CA229754S/en
Priority to CA229753Fprioritypatent/CA229753S/en
Priority to CA229751Fprioritypatent/CA229751S/en
Assigned to GENENTECH, INC.reassignmentGENENTECH, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: Phillips-Medisize, LLC
Assigned to Phillips-Medisize, LLCreassignmentPhillips-Medisize, LLCASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: BIANCHI, KEITH GERALD
Assigned to GENENTECH, INC.reassignmentGENENTECH, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: DOUGLASS, DANIEL CHRISTOPHER, HORVATH, JOSHUA DAVID, HOVATEN, Kristof
Publication of USD1033637S1publicationCriticalpatent/USD1033637S1/en
Application grantedgrantedCritical
Assigned to GENENTECH, INC.reassignmentGENENTECH, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: Phillips-Medisize, LLC
Assigned to Phillips-Medisize, LLCreassignmentPhillips-Medisize, LLCASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: BIANCHI, KEITH GERALD
Assigned to GENENTECH, INC.reassignmentGENENTECH, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: DOUGLASS, DANIEL CHRISTOPHER, HORVATH, JOSHUA DAVID, HOVATEN, Kristof
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Images

Description

FIG.1 is a bottom, front, and right side perspective view of a fluid exchange device of our design;
FIG.2 is a top, front, and left side perspective view thereof;
FIG.3 is a bottom, rear, and right side perspective view thereof;
FIG.4 is a right side view thereof;
FIG.5 is a left side view thereof;
FIG.6 is a rear view thereof;
FIG.7 is a front view thereof;
FIG.8 is a bottom view thereof;
FIG.9 is a top view thereof;
FIG.10 is an enlarged view taken fromFIG.1; and,
FIG.11 is an enlarged view taken fromFIG.2.
The dash-dash broken lines illustrate portions of the fluid exchange device that form no part of the claimed design.

Claims (1)

    CLAIM
  1. The ornamental design for a fluid exchange device, as shown and described.
US29/824,3542022-01-242022-01-24Fluid exchange deviceActiveUSD1033637S1 (en)

Priority Applications (20)

Application NumberPriority DateFiling DateTitle
US29/824,354USD1033637S1 (en)2022-01-242022-01-24Fluid exchange device
JP2022015578FJP1739057S (en)2022-01-242022-07-21 fluid changer
TW112301574FTWD227104S (en)2022-01-242022-07-21Fluid exchange device
JP2023008514FJP1747386S (en)2022-01-242022-07-21 fluid changer
TW112301571FTWD227102S (en)2022-01-242022-07-21Fluid exchange device
TW112301573FTWD227103S (en)2022-01-242022-07-21Fluid exchange device
JP2023000956FJP1747368S (en)2022-01-242022-07-21 fluid changer
JP2023008515FJP1747387S (en)2022-01-242022-07-21 fluid changer
JP2023008518FJP1747388S (en)2022-01-242022-07-21 fluid changer
TW111303604FTWD226875S (en)2022-01-242022-07-21Fluid exchange device
JP2023008513FJP1747385S (en)2022-01-242022-07-21 fluid changer
TW112301575FTWD227105S (en)2022-01-242022-07-21Fluid exchange device
TW112301576FTWD227106S (en)2022-01-242022-07-21Fluid exchange device
TW112301572FTWD226850S (en)2022-01-242022-07-21Fluid exchange device
JP2023008516FJP1751600S (en)2022-01-242022-07-21 fluid changer
CA229752FCA229752S (en)2022-01-242022-07-22Fluid exchange device
CA229754FCA229754S (en)2022-01-242022-07-22Fluid exchange device
CA229753FCA229753S (en)2022-01-242022-07-22Fluid exchange device
CA229751FCA229751S (en)2022-01-242022-07-22Fluid exchange device
CA214446FCA214446S (en)2022-01-242022-07-22Fluid exchange device

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US29/824,354USD1033637S1 (en)2022-01-242022-01-24Fluid exchange device

Publications (1)

Publication NumberPublication Date
USD1033637S1true USD1033637S1 (en)2024-07-02

Family

ID=85503509

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US29/824,354ActiveUSD1033637S1 (en)2022-01-242022-01-24Fluid exchange device

Country Status (4)

CountryLink
US (1)USD1033637S1 (en)
JP (7)JP1739057S (en)
CA (5)CA229753S (en)
TW (7)TWD227104S (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
USD1039687S1 (en)2021-11-242024-08-20Iantrek, Inc.Ocular implant delivery device
USD1018842S1 (en)*2021-11-242024-03-19Iantrek, Inc.Cannula assembly for an ocular implant delivery device
USD1033637S1 (en)*2022-01-242024-07-02Forsight Vision4, Inc.Fluid exchange device

Citations (468)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US134128A (en)*1872-12-24Improvement in blasting-fuses
US170342A (en)*1875-11-23Improvement in attachments for dental engines
CA134128A (en)*1911-02-271911-06-27William H. West Jr.Window pane fastener
CA170342A (en)*1916-02-111916-06-20Melvin L. SeveryOrthopedic device
US1747814A (en)1927-10-031930-02-18Gulf Production CompanyAutomatic switcher device for oil-storage tanks
US2564977A (en)1949-01-191951-08-21Hu Quang HsiMedical injecting apparatus
US2585815A (en)1947-01-161952-02-12Mclintock Duncan MenziesInjection syringe
US2646042A (en)1951-05-181953-07-21Hu Quang HsiMedical apparatus
US2886497A (en)1957-04-121959-05-12United States Steel CorpMethod for determining the permeability of steel to hydrogen
US3232117A (en)1962-09-141966-02-01Roger Gilmont Instr IncMicrometer buret
US3416530A (en)1966-03-021968-12-17Richard A. NessEyeball medication dispensing tablet
US3612089A (en)1968-10-281971-10-12Torit CorpVacuum reactivator
US3618604A (en)1969-06-091971-11-09Alza CorpOcular insert
US3641237A (en)1970-09-301972-02-08Nat Patent Dev CorpZero order release constant elution rate drug dosage
US3734095A (en)1971-05-211973-05-22L SantomieriFluid infusion
US3828777A (en)1971-11-081974-08-13Alza CorpMicroporous ocular device
US3831583A (en)1971-03-051974-08-27Univ CaliforniaImplantable bulb for inflation of surgical implements
US3845201A (en)1972-04-241974-10-29S LoucasSolid state ophthalmic medication delivery method
US3902495A (en)1974-01-281975-09-02Cavitron CorpFlow control system
US3914402A (en)1973-06-141975-10-21Alza CorpOphthalmic dosage form, for releasing medication over time
US3916899A (en)1973-04-251975-11-04Alza CorpOsmotic dispensing device with maximum and minimum sizes for the passageway
US3926188A (en)1974-11-141975-12-16Alza CorpLaminated drug dispenser
US3949750A (en)1974-10-071976-04-13Freeman Jerre MPunctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US3949748A (en)1974-09-261976-04-13Oscar MalminInjection syringe having aspirating and metering capabilities
US3961628A (en)1974-04-101976-06-08Alza CorporationOcular drug dispensing system
US3977404A (en)1975-09-081976-08-31Alza CorporationOsmotic device having microporous reservoir
US3995635A (en)1971-09-091976-12-07Alza CorporationOcular insert
US4008719A (en)1976-02-021977-02-22Alza CorporationOsmotic system having laminar arrangement for programming delivery of active agent
US4014334A (en)1976-02-021977-03-29Alza CorporationLaminated osmotic system for dispensing beneficial agent
US4014335A (en)1975-04-211977-03-29Alza CorporationOcular drug delivery device
US4014333A (en)1975-09-221977-03-29Mcintyre David JInstrument for aspirating and irrigating during ophthalmic surgery
US4034756A (en)1971-01-131977-07-12Alza CorporationOsmotically driven fluid dispenser
US4034758A (en)1975-09-081977-07-12Alza CorporationOsmotic therapeutic system for administering medicament
US4077407A (en)1975-11-241978-03-07Alza CorporationOsmotic devices having composite walls
US4111203A (en)1976-11-221978-09-05Alza CorporationOsmotic system with means for improving delivery kinetics of system
US4111201A (en)1976-11-221978-09-05Alza CorporationOsmotic system for delivering selected beneficial agents having varying degrees of solubility
US4135514A (en)1974-12-231979-01-23Alza CorporationOsmotic releasing system for administering ophthalmic drug to eye of animal
US4160452A (en)1977-04-071979-07-10Alza CorporationOsmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4164559A (en)1977-09-211979-08-14Cornell Research Foundation, Inc.Collagen drug delivery device
US4179497A (en)1973-12-171979-12-18Merck & Co., Inc.Solid state ophthalmic medication
US4186184A (en)1977-12-271980-01-29Alza CorporationSelective administration of drug with ocular therapeutic system
US4200098A (en)1978-10-231980-04-29Alza CorporationOsmotic system with distribution zone for dispensing beneficial agent
US4220153A (en)1978-05-081980-09-02Pfizer Inc.Controlled release delivery system
US4220152A (en)1978-05-081980-09-02Pfizer Inc.Delivery system
US4256108A (en)1977-04-071981-03-17Alza CorporationMicroporous-semipermeable laminated osmotic system
US4298000A (en)1978-11-081981-11-03Minnesota Mining And Manufacturing CompanyFluid dispensing device
US4300557A (en)1980-01-071981-11-17The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesMethod for treating intraocular malignancies
US4309776A (en)1980-05-131982-01-12Ramon BerguerIntravascular implantation device and method of using the same
US4326525A (en)1980-10-141982-04-27Alza CorporationOsmotic device that improves delivery properties of agent in situ
US4327725A (en)1980-11-251982-05-04Alza CorporationOsmotic device with hydrogel driving member
US4343787A (en)1975-07-291982-08-10Merck & Co., Inc.Shaped ophthalmic inserts for treating dry eye syndrome
US4439196A (en)1982-03-181984-03-27Merck & Co., Inc.Osmotic drug delivery system
US4439198A (en)1981-07-091984-03-27University Of Illinois FoundationBiodegradable ocular insert for controlled delivery of ophthalmic medication
EP0033042B1 (en)1980-01-281984-08-22Merck & Co. Inc.Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors
US4475916A (en)1982-03-181984-10-09Merck & Co., Inc.Osmotic drug delivery system
US4484922A (en)1981-06-251984-11-27Rosenwald Peter LOccular device
US4519801A (en)1982-07-121985-05-28Alza CorporationOsmotic device with wall comprising cellulose ether and permeability enhancer
US4609374A (en)1985-04-221986-09-02Alza CorporationOsmotic device comprising means for governing initial time of agent release therefrom
US4627850A (en)1983-11-021986-12-09Alza CorporationOsmotic capsule
US4634418A (en)1984-04-061987-01-06Binder Perry SHydrogel seton
US4634427A (en)1984-09-041987-01-06American Hospital Supply CompanyImplantable demand medication delivery assembly
US4673405A (en)1983-03-041987-06-16Alza CorporationOsmotic system with instant drug availability
EP0228185A1 (en)1985-11-271987-07-08Thomas C. WhiteTissue-implantable fluid-dissipating device
US4693886A (en)1985-04-221987-09-15Alza CorporationOsmotic device with inert core
US4712550A (en)1985-04-081987-12-15Sinnett Kevin BRetinal tack
US4730013A (en)1981-10-081988-03-08Merck & Co., Inc.Biosoluble ocular insert
US4737150A (en)1985-05-101988-04-12Intermedicat GmbhTwo-cannula syringe
WO1988004573A1 (en)1986-12-231988-06-30The Liposome Company, Inc.Liposome preparation and antibiotic
US4774091A (en)1983-10-141988-09-27Sumitomo Pharmaceuticals Company, Ltd.Long-term sustained-release preparation
US4777049A (en)1983-12-011988-10-11Alza CorporationConstant release system with pulsed release
US4781675A (en)1985-11-271988-11-01White Thomas CInfusion cannula
JPH01149716A (en)1987-10-261989-06-12Alza CorpDrug administration system
US4851228A (en)1984-06-201989-07-25Merck & Co., Inc.Multiparticulate controlled porosity osmotic
JPH01197429A (en)1988-01-301989-08-09Olympus Optical Co LtdCeramics impregnated with medicament liquid
US4863457A (en)1986-11-241989-09-05Lee David ADrug delivery device
US4865846A (en)1988-06-031989-09-12Kaufman Herbert EDrug delivery system
US4883459A (en)1983-07-291989-11-28Reynaldo CalderonRetrograde perfusion
WO1990007545A2 (en)1988-12-301990-07-12Anderson David MStabilized microporous materials and hydrogel materials
US4959217A (en)1986-05-221990-09-25Syntex (U.S.A.) Inc.Delayed/sustained release of macromolecules
US4979938A (en)1989-05-111990-12-25Iomed, Inc.Method of iontophoretically treating acne, furuncles and like skin disorders
US5049142A (en)1984-11-071991-09-17Herrick Robert SIntracanalicular implant for horizontal canalicular blockade treatment of the eye
US5053030A (en)1984-11-071991-10-01Herrick Robert SIntracanalicular implant for horizontal canalicular blockade treatment of the eye
US5084021A (en)1990-11-021992-01-28Baldwin Brian EPatient controlled infusion apparatus and method
US5098443A (en)1989-03-231992-03-24University Of MiamiMethod of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5128145A (en)1990-06-131992-07-07Alza CorporationDosage form for Parkinson's disease, spasticity and muscle spasms
US5141748A (en)1989-02-171992-08-25Hoffmann-La Roche, Inc.Implant drug delivery device
US5147647A (en)1986-10-021992-09-15Sohrab DarougarOcular insert for the fornix
US5164188A (en)1989-11-221992-11-17Visionex, Inc.Biodegradable ocular implants
US5171270A (en)1990-03-291992-12-15Herrick Robert SCanalicular implant having a collapsible flared section and method
US5174999A (en)1988-12-131992-12-29Alza CorporationDelivery system comprising fluid ingress and drug egress
US5238687A (en)1990-07-111993-08-24Alza CorporationDelivery device with a protective sleeve
US5273530A (en)1990-11-141993-12-28The University Of RochesterIntraretinal delivery and withdrawal instruments
US5277912A (en)1991-04-051994-01-11Eli Lilly And CompanySustained release capsule and formulations
US5282829A (en)1991-08-151994-02-01United States Surgical CorporationHollow body implants
US5300114A (en)1992-05-041994-04-05Allergan, Inc.Subconjunctival implants for ocular drug delivery
US5322691A (en)1986-10-021994-06-21Sohrab DarougarOcular insert with anchoring protrusions
US5322504A (en)1992-05-071994-06-21United States Surgical CorporationMethod and apparatus for tissue excision and removal by fluid jet
US5324518A (en)1989-12-081994-06-28Biosynthesis, Inc.Implantable structure for containing substances for delivery to a body
US5334189A (en)1991-06-031994-08-02Wade Stephen EDevice for controlled diffusion of a chemical substance
US5336175A (en)1992-10-291994-08-09Mames Robert NMethod for the treatment of retinal detachments
US5358473A (en)1993-04-301994-10-25Mitchell Paul GApparatus and method for the removal of adherent viscoelastic material
US5364343A (en)1991-03-061994-11-15D.D. S.R.L.Irrigation device for use in ear canals for therapeutic or hygienic purposes
US5378475A (en)1991-02-211995-01-03University Of Kentucky Research FoundationSustained release drug delivery devices
US5413572A (en)1990-04-021995-05-09Alza CorporationOsmotic dosage system for liquid drug delivery
US5443505A (en)1993-11-151995-08-22Oculex Pharmaceuticals, Inc.Biocompatible ocular implants
EP0671165A2 (en)1994-02-091995-09-13Collagen CorporationCollagen-based injectable drug delivery system and its use
WO1995028984A1 (en)1994-04-251995-11-02Escalon Ophthalmics, Inc.Tack for intraocular drug delivery and method for inserting and removing same
US5476448A (en)1994-10-191995-12-19Urich; AlexApparatus for suppressing a vacuum surge in eye surgery
US5554132A (en)1995-03-301996-09-10Abbott LaboratoriesHand grip for use with syringe
US5578042A (en)1994-03-141996-11-26Cumming; J. StuartOphthalmic kit and method for lens insertion
WO1997029850A1 (en)1996-02-151997-08-21Nomix-Chipman LimitedSpray gun
US5674193A (en)1995-04-051997-10-07Hayes; Lili L.Oral/nasal-gastric drainage kit
US5681572A (en)1991-10-181997-10-28Seare, Jr.; William J.Porous material product and process
US5725493A (en)1994-12-121998-03-10Avery; Robert LoganIntravitreal medicine delivery
US5755684A (en)1996-12-201998-05-26Chen; Jen-YieVolume homeostatic fluid-fluid exchanger
WO1998025982A1 (en)1996-12-131998-06-18Novartis AgPorous polyorganosiloxane polymers
US5770076A (en)1994-03-071998-06-23The Regents Of The University Of CaliforniaMicromachined capsules having porous membranes and bulk supports
US5773019A (en)1995-09-271998-06-30The University Of Kentucky Research FoundationImplantable controlled release device to deliver drugs directly to an internal portion of the body
US5792099A (en)1995-02-141998-08-11Decamp; DennisSyringe and cannula for insertion of viscoelastic material into an eye and method of using same
US5797898A (en)1996-07-021998-08-25Massachusetts Institute Of TechnologyMicrochip drug delivery devices
US5817075A (en)1989-08-141998-10-06Photogenesis, Inc.Method for preparation and transplantation of planar implants and surgical instrument therefor
WO1998043611A1 (en)1997-03-311998-10-08Alza CorporationDiffusional implantable delivery system
US5830546A (en)1991-10-031998-11-03Holvis Holzstoff S.A.Reservoir system for prolonged diffusion of an active principle
US5836935A (en)1994-11-101998-11-17Ashton; PaulImplantable refillable controlled release device to deliver drugs directly to an internal portion of the body
US5868697A (en)1995-05-141999-02-09Optonol Ltd.Intraocular implant
WO1999011244A1 (en)1997-08-281999-03-11Control Delivery Systems, Inc.Sustained release drug delivery devices
US5916584A (en)1994-10-251999-06-29Daratech Proprietary LimitedControlled release container with core and outer shell
US5928662A (en)1996-07-311999-07-27Phillips; Andrew F.Ocular drug delivery device
US5951512A (en)1996-05-281999-09-14Horizon Medical Products, Inc.Infusion port with modified drug reservoir
US5968008A (en)1997-08-041999-10-19Grams; Guenter A.Cannula with parallel channels and sliding sheath
US5985328A (en)1994-03-071999-11-16Regents Of The University Of CaliforniaMicromachined porous membranes with bulk support
WO2000048660A1 (en)1999-02-182000-08-24Alcove Surfaces GmbhImplant
US6196993B1 (en)1998-04-202001-03-06Eyelab Group, LlcOphthalmic insert and method for sustained release of medication to the eye
WO2001026714A1 (en)1999-10-122001-04-19Durect CorporationRegulation of drug delivery through flow diversion
WO2001050943A2 (en)2000-01-122001-07-19Becton, Dickinson And CompanySystems and methods for reducing intraocular pressure
WO2001068016A2 (en)2000-03-112001-09-20Johns Hopkins UniversitySutureless ocular surgical methods and instruments
US6303290B1 (en)2000-09-132001-10-16The Trustees Of The University Of PennsylvaniaEncapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
US6331523B1 (en)1998-03-122001-12-18Genentech, Inc.Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5
US6331313B1 (en)1999-10-222001-12-18Oculex Pharmaceticals, Inc.Controlled-release biocompatible ocular drug delivery implant devices and methods
US20020026176A1 (en)2000-08-302002-02-28Varner Signe EricksonDevices for intraocular drug delivery
US6375972B1 (en)2000-04-262002-04-23Control Delivery Systems, Inc.Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US20020049389A1 (en)1996-09-042002-04-25Abreu Marcio MarcNoninvasive measurement of chemical substances
US6395300B1 (en)1999-05-272002-05-28Acusphere, Inc.Porous drug matrices and methods of manufacture thereof
US6413540B1 (en)1999-10-212002-07-02Alcon Universal Ltd.Drug delivery device
US20020086051A1 (en)2001-01-032002-07-04Santos ViscasillasSustained release drug delivery devices with coated drug cores
US6416777B1 (en)1999-10-212002-07-09Alcon Universal Ltd.Ophthalmic drug delivery device
WO2002053128A2 (en)2001-01-032002-07-11Bausch & Lomb IncorporatedSustained release drug delivery devices with multiple agents
US6420399B1 (en)1999-06-182002-07-16Alcon Manufacturing, Ltd.Topical ophthalmic mast cell stabilizers for treating allergic eye disease
US20020106395A1 (en)2001-01-032002-08-08Brubaker Michael J.Sustained release drug delivery devices with prefabricated permeable plugs
US20020110591A1 (en)2000-12-292002-08-15Brubaker Michael J.Sustained release drug delivery devices
US20020110635A1 (en)2001-01-262002-08-15Brubaker Michael J.Process for the production of sustained release drug delivery devices
US6468264B1 (en)1999-10-122002-10-22Durect CorporationClosed exchange system
US6472162B1 (en)1999-06-042002-10-29Thermogenesis Corp.Method for preparing thrombin for use in a biological glue
US20020165522A1 (en)2001-05-032002-11-07Jorgen HolmenMethod for use in cataract surgery
US20020188244A1 (en)2001-05-312002-12-12Alan SmithDevice and method for colonic lavage
WO2002100318A2 (en)2001-06-122002-12-19Johns Hopkins University School Of MedicineReservoir device for intraocular drug delivery
US20030005945A1 (en)2000-03-132003-01-09Hiroyuki OnishiMethod for surface-treatment, surface-treated article and device for surface treatment
US20030047011A1 (en)2000-02-252003-03-13Ulrich DiermannMicro perfusion device comprising a collecting container
WO2003028765A1 (en)2001-09-282003-04-10Santen Pharmaceutical Co., Ltd.Injections for eye tissue containing drug bound to polyethylene glycol
US20030119177A1 (en)2001-11-152003-06-26Lewis GruberSample chip
US20030120217A1 (en)2001-12-212003-06-26Abergel R. PatrickMethods and devices for sclerotherapy
US20030118649A1 (en)2001-10-042003-06-26Jinming GaoDrug delivery devices and methods
US6605066B1 (en)1998-09-182003-08-12Imedex BiomateriauxDevice for forming and delivering a mixture
US6620139B1 (en)1998-12-142003-09-16Tre Esse Progettazione Biomedica S.R.L.Catheter system for performing intramyocardiac therapeutic treatment
US20030176854A1 (en)2002-03-112003-09-18Alcon, Inc.Implantable drug delivery system
US20030185872A1 (en)2002-03-272003-10-02Frank KochinkeMethods and drug delivery systems for the treatment of orofacial diseases
US20030212383A1 (en)2001-01-052003-11-13Dana CoteSystem and methods for reducing intraocular pressure
US20030233067A1 (en)2002-06-142003-12-18Mcintosh Kevin D.Multiple ratio fluid dispenser
US20030235603A1 (en)2002-06-192003-12-25Schwarz Marlene C.Multiphase polymeric drug release region
US20040010228A1 (en)*2001-09-252004-01-15Becton, Dickinson And CompanyActivation of dual blunting needle assembly
US20040011651A1 (en)1996-01-312004-01-22Board Of Regents, The University Of Texas SystemMethod and apparatus for fractionation using conventional dielectrophoresis and field flow fractionation
US20040019325A1 (en)2002-07-292004-01-29Medrip Ltd.Syringe Pump
US6685940B2 (en)1995-07-272004-02-03Genentech, Inc.Protein formulation
EP1385452A1 (en)2001-07-232004-02-04Alcon, Inc.Ophthalmic drug delivery device
US20040029832A1 (en)2002-05-172004-02-12Zeldis Jerome B.Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
US6695821B1 (en)1998-06-172004-02-24Raymond N. SjaardaSurgical infusion tool with flow diffuser
US6713081B2 (en)2001-03-152004-03-30The United States Of America As Represented By The Department Of Health And Human ServicesOcular therapeutic agent delivery devices and methods for making and using such devices
EP1409065A2 (en)2001-07-232004-04-21Alcon, Inc.Ophthalmic drug delivery device
US20040171997A1 (en)2001-01-242004-09-02Wilson Jon S.Double-y-shaped multi-lumen catheter with selectively attachable hubs
US20040209359A1 (en)2001-07-192004-10-21Avner YayonPlasma protein matrices and methods for their preparation
US20040230183A1 (en)2003-02-182004-11-18Wisam BreegiDrug delivery device and syringe for filling the same
US20040247487A1 (en)2001-03-022004-12-09Pierre CommerconMeans for extracting products to be analysed and applications thereof in diagnosis and analysis
US20040260381A1 (en)2003-06-182004-12-23D-Crown LtdDevices and methods for forming stenting structures in situ
US20040260380A1 (en)2003-06-182004-12-23D-Crown LtdDevices for delivering multiple stenting structures in situ
US20040260240A1 (en)2002-06-102004-12-23Dagmar BeyerleinSystems and methods for detecting tissue contact and needle penetration depth using static fluid pressure measurements
WO2004112653A2 (en)2003-06-182004-12-29D-Crown Ltd.Devices and methods for delivering and forming single and multiple stenting structures in situ
WO2005016401A2 (en)2003-06-132005-02-24Becton Dickinson And CompanyImproved intra-dermal delivery of biologically active agents
US20050049578A1 (en)2000-04-142005-03-03Hosheng TuImplantable ocular pump to reduce intraocular pressure
US6869412B2 (en)2000-11-132005-03-22Edward Allan RossMethod and device for intravascular plasma fluid removal
US20050064010A1 (en)2003-09-182005-03-24Cooper Eugene R.Transscleral delivery
WO2005025413A2 (en)2003-09-112005-03-24Theranos, Inc.Medical device for analyte monitoring and drug delivery
WO2005028006A1 (en)2003-09-242005-03-31Medi-Stream Pty LtdMedication holder
US20050074497A1 (en)2003-04-092005-04-07Schultz Clyde L.Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US20050112759A1 (en)2003-06-202005-05-26Milica RadisicApplication of electrical stimulation for functional tissue engineering in vitro and in vivo
US20050113806A1 (en)2001-08-292005-05-26De Carvalho Ricardo A.P.Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
US20050119737A1 (en)2000-01-122005-06-02Bene Eric A.Ocular implant and methods for making and using same
US20050143363A1 (en)2002-09-292005-06-30Innorx, Inc.Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases
US20050154399A1 (en)2002-09-182005-07-14Allergan, Inc.Apparatus for delivery of ocular implants
US20050171491A1 (en)2004-01-292005-08-04Becton, Dickinson And CompanyIntravenous delivery system
US20050181018A1 (en)2003-09-192005-08-18Peyman Gholam A.Ocular drug delivery
WO2005091922A2 (en)2004-03-032005-10-06Becton, Dickinson And CompanyMethods and devices for improving delivery of a substance to skin
US20050244472A1 (en)2004-04-302005-11-03Allergan, Inc.Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
US20050244469A1 (en)2004-04-302005-11-03Allergan, Inc.Extended therapeutic effect ocular implant treatments
US20050244467A1 (en)2004-04-302005-11-03Allergan, Inc.Extended release biodegradable ocular implants
US20050256462A1 (en)2004-05-142005-11-17Underwood John RNozzle
US20050255144A1 (en)2003-04-092005-11-17Directcontact LlcMethods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US20050271703A1 (en)2003-05-022005-12-08Anderson Aron BControlled release bioactive agent delivery device
US20050277802A1 (en)2004-02-122005-12-15Larsen Charles EMethod and apparatus for intraocular brachytherapy
US6976982B2 (en)2001-01-092005-12-20Microchips, Inc.Flexible microchip devices for ophthalmic and other applications
WO2006015385A2 (en)2004-08-062006-02-09Sopherion Therapeutics, Inc.Anti-angiogenic peptides and methods of use thereof
WO2006014484A2 (en)2004-07-022006-02-09Surmodics, Inc.Methods and devices for the treatment of ocular conditions
US20060039952A1 (en)2003-07-102006-02-23Yoseph YaacobiOphthalmic drug delivery device
WO2006023530A2 (en)2004-08-162006-03-02Massachusetts Institute Of TechnologyCompositions and methods for enhancing structural and functional nervous system reorganization and recovery
US20060052754A1 (en)2004-09-042006-03-09Fields Douglas WThumb trigger syringe pole
US20060057277A1 (en)2004-09-102006-03-16Chappa Ralph AMethods, devices, and coatings for controlled active agent release
WO2006031358A2 (en)2004-08-132006-03-23Hyperbranch Medical Technology, Inc.Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
WO2006031388A2 (en)2004-08-202006-03-23Hyperbranch Medical Technology, Inc.Dentritic polymers, crosslinked gels, and their uses in orthopedic applications
US20060073182A1 (en)2004-10-012006-04-06Wong Vernon GConveniently implantable sustained release drug compositions
US7026329B2 (en)1992-09-212006-04-11Albert Einstein College Of Medicine Of Yeshiva UniversityMethod of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
WO2006044614A2 (en)2004-10-142006-04-27Sopherion Therapeutics, Inc.Anti-angiogenic peptides and methods of use thereof
WO2006050221A2 (en)2004-10-292006-05-11The Regents Of The University Of CaliforniaPorous photonic crystals for drug delivery to the eye
US20060116626A1 (en)2002-03-072006-06-01Gregory SmedleyFluid infusion methods for glaucoma treatment
US20060129215A1 (en)2004-12-092006-06-15Helmus Michael NMedical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery
EP1671624A1 (en)2003-05-022006-06-21SurModics, Inc.Delivery device for a controlled drug release of an active agent into the posterior section of the eye
US20060154981A1 (en)2005-01-122006-07-13Alcon, Inc.Method of reducing intraocular pressure and treating glaucoma
WO2006082588A2 (en)2005-02-072006-08-10Pharmalight Inc.Method and device for ophthalmic administration of active pharmaceutical ingredients
US7090681B2 (en)2002-09-182006-08-15Allergan, Inc.Methods and apparatus for delivery of ocular implants
US20060182783A1 (en)2004-04-302006-08-17Allergan, Inc.Sustained release intraocular drug delivery systems
US7094222B1 (en)2003-04-282006-08-22The United States Of America As Represented By The Secretary Of NavySyringe device for simultaneous infusion and withdrawal
US20060189608A1 (en)2005-02-232006-08-24Alcon, Inc.Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
US20060200097A1 (en)2003-01-242006-09-07Doheny Retina InstituteReservoirs with subretinal cannula for subretinal drug delivery
US7117870B2 (en)2004-07-262006-10-10Clarity CorporationLacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
WO2006108054A2 (en)2005-04-052006-10-12The Ohio State UniversityDiffusion delivery system and methods of fabrication
US20060233858A1 (en)2005-03-082006-10-19Allergan, Inc.Systems and methods providing targeted intraocular drug delivery
US20060246112A1 (en)2002-01-182006-11-02Snyder Michael ESustained release ophthalmological device and method of making and using the same
US20060258994A1 (en)2005-05-122006-11-16Avery Robert LImplantable delivery device for administering pharmacological agents to an internal portion of a body
US20060258000A1 (en)2003-02-262006-11-16Allen Jared WUse of steady-state oxygen gradients to modulate animal cell functions
US20060257450A1 (en)2005-03-212006-11-16Sreenivasu MudumbaDrug delivery systems for treatment of diseases or conditions
US7141152B2 (en)2000-03-162006-11-28Le Febre David AAnalyte species separation system
WO2006127962A2 (en)2005-05-252006-11-30Becton, Dickinson And ComapnyParticulate formulations for intradermal delivery of biologically active agents
WO2006138609A2 (en)2005-06-172006-12-28Dynamis Therapeutics, Inc.Treatment of inflammatory conditions
US20070020336A1 (en)2005-07-222007-01-25Oculis EhfCyclodextrin nanotechnology for ophthalmic drug delivery
US20070026037A1 (en)2005-07-292007-02-01Kloke Timothy MDevices, articles, coatings, and methods for controlled active agent release or hemocompatibility
US7181287B2 (en)2001-02-132007-02-20Second Sight Medical Products, Inc.Implantable drug delivery device
US20070059336A1 (en)2004-04-302007-03-15Allergan, Inc.Anti-angiogenic sustained release intraocular implants and related methods
US7195774B2 (en)2001-08-292007-03-27Carvalho Ricardo Azevedo PonteImplantable and sealable system for unidirectional delivery of therapeutic agents to tissues
US7195778B2 (en)2001-07-102007-03-27Teva Pharmaceutical Industries Ltd.Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
WO2007035621A1 (en)2005-09-162007-03-29(Osi) Eyetech, Inc.Ophthalmic syringe
US20070072933A1 (en)2005-09-262007-03-29Peyman Gholam ADelivery of an ocular agent
US20070071756A1 (en)2005-09-262007-03-29Peyman Gholam ADelivery of an agent to ameliorate inflammation
WO2007035473A2 (en)2005-09-152007-03-29Roth Daniel BPharmaceutical delivery device and method for providing ocular treatment
WO2007038453A2 (en)2005-09-262007-04-05Advanced Ocular Systems LimitedUse of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
US20070077270A1 (en)2005-03-282007-04-05Clemson UniversityDelivery devices and methods for long-term, targeted delivery of therapeutic agents to the eye and ear
US20070078359A1 (en)2005-08-102007-04-05Luloh K PTool For Extracting Vitreous Samples From An Eye
US20070083155A1 (en)2005-09-272007-04-12Mile Creek Capital, LlcMulti-lumen injection apparatus
WO2007044534A2 (en)2005-10-062007-04-19Trophogen, Inc.Vegf analogs and methods of use
WO2007047744A2 (en)2005-10-142007-04-26Alcon, Inc.Method for treating primary and secondary forms of glaucoma
US7211272B2 (en)2003-12-222007-05-01Bausch & Lomb IncorporatedDrug delivery device
US20070128644A1 (en)2005-12-012007-06-07Canon Kabushiki KaishaFluid control method and fluid control apparatus
US20070131611A1 (en)2005-12-132007-06-14General Electric CompanyMembrane-based article and associated method
US20070131610A1 (en)2005-12-132007-06-14General Electric CompanyMembrane-based apparatus and associated method
US20070134305A1 (en)2005-12-072007-06-14Ramot At Tel Aviv University Ltd.Drug-delivering composite structures
US20070141111A1 (en)2003-08-202007-06-21Bioretec OyPorous medical device and method for its manufacture
WO2007084582A2 (en)2006-01-172007-07-26Forsight Labs, LlcDrug delivery treatment device
WO2007084765A2 (en)2006-01-192007-07-26Potentia Pharmaceuticals, Inc.Injectable combination therapy for eye disorders
US20070191863A1 (en)2006-01-172007-08-16De Juan Eugene JrGlaucoma Treatment Device
US20070203174A1 (en)2006-02-272007-08-30Alcon Manufacturing, Ltd.Method of treating glaucoma
US20070212388A1 (en)2006-03-082007-09-13Sahajanand Medical Technologies Pvt. Ltd.Compositions comprising porous articles and uses in implantable medical devices
US20070219632A1 (en)2002-08-022007-09-20David CastillejosMethod and intra-sclera implant for treatment of glaucoma and presbyopia
US7276050B2 (en)2004-03-022007-10-02Alan FranklinTrans-scleral drug delivery method and apparatus
WO2007115259A2 (en)2006-03-312007-10-11Qlt Plug Delivery, Inc.Nasolacrimal drainage system implants for drug therapy
US20070235331A1 (en)2003-07-252007-10-11Dexcom, Inc.Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
WO2007117394A2 (en)2006-03-312007-10-18Dynamis Therapeutics, Inc.Compositions and methods related to fructosamine-3-kinase inhibitors
US20070260201A1 (en)2006-05-022007-11-08Georgia Tech Research CorporationMethod for drug delivery to ocular tissue using microneedle
US20070265599A1 (en)2006-05-122007-11-15David CastillejosOptic nerve head implant and medication delivery system
EP1337284B1 (en)2000-09-062007-12-05Alcon Inc.Switchable tackiness coating compositions for ophthalmic implants
WO2008003043A2 (en)2006-06-282008-01-03Surmodics, Inc.Combination degradable and non-degradable matrices for active agent delivery
US20080004329A1 (en)2006-06-292008-01-03Jazz PharmaceuticalsPharmaceutical compositions of ropinirole and methods of use thereof
US20080003219A1 (en)2005-09-262008-01-03Minu, L.L.C.Delivery of an ocular agent
US20080015545A1 (en)2006-05-172008-01-17Robert SanchezDual Thermal Coefficient Dispensing Chamber
WO2008011125A2 (en)2006-07-202008-01-24Neurosystec CorporationDevices, systems and methods for ophthalmic drug delivery
US20080038316A1 (en)2004-10-012008-02-14Wong Vernon GConveniently implantable sustained release drug compositions
WO2008019265A2 (en)2006-08-042008-02-14Allergan, Inc.Ocular implant delivery assemblies
US20080057561A1 (en)2006-08-292008-03-06Canon Kabushiki KaishaCell culture treatment apparatus and cell culture treatment method
US20080069854A1 (en)2006-08-022008-03-20Inframat CorporationMedical devices and methods of making and using
WO2008033924A2 (en)2006-09-122008-03-20Board Of Regents Of The University Of NebraskaMethods and compositions for targeted delivery of therapeutic agents
US20080066741A1 (en)2006-09-202008-03-20Lemahieu EdwardMethods and systems of delivering medication via inhalation
WO2008040062A1 (en)2006-10-052008-04-10Medi-Stream Pty LtdMedication holder
WO2008045272A2 (en)2006-10-062008-04-17Dynamis Therapeutics, Inc.Compositions and methods for skin lightening
US20080089923A1 (en)2006-09-292008-04-17Burkstrand Michael JBiodegradable ocular implants and methods for treating ocular conditions
WO2008052145A2 (en)2006-10-252008-05-02Revalesio CorporationMethods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
US20080108954A1 (en)2006-11-022008-05-08Jean-Marie MathiasFlow Controllers
US20080111282A1 (en)2006-11-102008-05-15Baojun XieProcess for Making Three Dimensional Objects From Dispersions of Polymer Colloidal Particles
WO2008061043A2 (en)2006-11-102008-05-22Glaukos CorporationUveoscleral shunt and methods for implanting same
US20080124372A1 (en)2006-06-062008-05-29Hossainy Syed F AMorphology profiles for control of agent release rates from polymer matrices
US20080145406A1 (en)2006-12-182008-06-19Alcon Manufacturing Ltd.Devices and methods for ophthalmic drug delivery
US20080147021A1 (en)2006-12-152008-06-19Jani Dharmendra MDrug delivery devices
US20080154241A1 (en)2006-12-072008-06-26Burkstrand Michael JLatent stabilization of bioactive agents releasable from implantable medical articles
US20080167600A1 (en)2005-09-262008-07-10Peyman Gholam ADevice for delivery of an agent to the eye and other sites
US20080181930A1 (en)2007-01-312008-07-31Alcon Research, Ltd.Punctal Plugs and Methods of Delivering Therapeutic Agents
US20080195218A1 (en)2007-02-142008-08-14Benoist Girard SasProsthetic implant for use without bone cement
US20080213611A1 (en)2007-01-192008-09-04Cinvention AgPorous, non-degradable implant made by powder molding
US20080216736A1 (en)2006-01-192008-09-11Takeda San Diego, Inc.Microfluidic device with diffusion between adjacent lumens
WO2008115290A2 (en)2006-10-252008-09-25Revalesio CorporationMethods of wound care and treatment
WO2008116165A2 (en)2007-03-212008-09-25Next Safety, Inc.Methods and systems of delivering medication via inhalation
US20080249501A1 (en)2007-04-092008-10-09Medtronic Vascular, Inc.Methods for Simultaneous Injection and Aspiration of Fluids During a Medical Procedure
US20080286338A1 (en)2007-05-152008-11-20Boston Foundation For SightDrug delivery system with scleral lens
US20080293691A1 (en)2005-11-292008-11-27Smithkline Beecham CorporationTreatment Method
US20080292679A1 (en)2007-05-242008-11-27Allergan, Inc.Biodegradable drug delivery system
WO2008144919A1 (en)2007-05-292008-12-04Angiochem, Inc.Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US20090005864A1 (en)1996-03-182009-01-01Eggleston Harry CModular intraocular implant
US20090012485A1 (en)2007-03-232009-01-08Michaels Thomas LFluid collection and disposal system having interchangeable collection and other features and methods relating thereto
US7476510B2 (en)1997-05-292009-01-13Cellomics, Inc.Miniaturized cell array methods and apparatus for cell-based screening
WO2009012075A1 (en)2007-07-162009-01-22Alcon, Inc.Use of iop-lowering agents for treating primary and secondary forms of glaucoma
US20090036827A1 (en)2007-07-312009-02-05Karl CazziniJuxtascleral Drug Delivery and Ocular Implant System
US20090043253A1 (en)2005-10-112009-02-12Blake PodaimaSmart medical compliance method and system
WO2009023615A1 (en)2007-08-102009-02-19Trustees Of Tufts CollegeTubular silk compositions and methods of use thereof
EP1521572B1 (en)2002-07-152009-03-04Alcon, Inc.Bioerodible film for ophthalmic drug delivery
US20090061071A1 (en)2007-08-312009-03-05Boston Scientific Scimed, Inc.Porous medical articles for therapeutic agent delivery
US20090074786A1 (en)2005-02-092009-03-19Macusight, Inc.Formulations for treating ocular diseases and conditions
US20090082631A1 (en)2007-09-242009-03-26Cronin Michael DElliptical retractor
US20090081271A1 (en)2007-09-242009-03-26John ClarkeMedical devices having a filter insert for controlled diffusion
US20090081272A1 (en)2007-09-242009-03-26John ClarkeMedical devices having a metal particulate composition for controlled diffusion
US20090093752A1 (en)2007-10-052009-04-09Tyco Healthcare Group LpSeal anchor for use in surgical procedures
US20090099626A1 (en)2007-09-072009-04-16Qlt Plug Delivery, Inc. - QpdiLacrimal implant detection
US20090104243A1 (en)2007-09-072009-04-23Qlt Plug Delivery, Inc. - QpdiDrug cores for sustained release of therapeutic agents
US20090105749A1 (en)2007-09-072009-04-23Qlt Plug Delivery, Inc. - QpdiInsertion and extraction tools for lacrimal implants
WO2009055620A1 (en)2007-10-252009-04-30Revalesio CorporationBacteriostatic or bacteriocidal compositions and methods
WO2009055671A1 (en)2007-10-252009-04-30Revalesio CorporationCompositions and methods for treating cystic fibrosis
WO2009055824A1 (en)2007-10-252009-04-30Revalesio CorporationCompositions and methods for treating asthma and lung disorders
WO2009061607A2 (en)2007-11-052009-05-14Bausch & Lomb IncorporatedWater-immiscible materials as vehicles for drug delivery
US20090124986A1 (en)2007-11-082009-05-14Terumo Kabushiki KaishaSprayer
WO2009073192A2 (en)2007-12-042009-06-11Landec CorporationSystems and methods for delivery of materials
USRE40755E1 (en)*2000-04-282009-06-23Mdc Investment Holdings, Inc.Needle-bearing medical device
WO2009086112A2 (en)2007-12-202009-07-09University Of Southern CaliforniaApparatus and methods for delivering therapeutic agents
WO2009089409A2 (en)2008-01-102009-07-16Bausch & Lomb IncorporatedIntravitreal injection system having coaxial cannulae and use thereof
US20090192493A1 (en)2008-01-032009-07-30University Of Southern CaliforniaImplantable drug-delivery devices, and apparatus and methods for refilling the devices
WO2009094466A2 (en)2008-01-222009-07-30University Of Florida Research Foundation, Inc.Contact lenses for extended release of bioactive agents containing diffusion attenuators
US20090196903A1 (en)2008-01-292009-08-06Kliman Gilbert HDrug delivery devices, kits and methods therefor
US20090214601A1 (en)2007-09-282009-08-27Chappa Ralph APorous Drug Delivery Devices and Related Methods
US20090224064A1 (en)2008-03-102009-09-10Vapore, Inc.Low Energy Vaporization of Liquids: Apparatus and Methods
WO2009112878A1 (en)2008-03-112009-09-17Raouf RekikDrug delivery to the anterior and posterior segments of the eye using eye drops.
US20090234449A1 (en)2007-12-272009-09-17De Juan Jr EugeneIntraocular, accommodating lens and methods of use
WO2009117112A2 (en)2008-03-212009-09-24Novartis AgPowder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents
US20090240208A1 (en)2008-03-192009-09-24Warsaw Orthopedic, Inc.Microparticle delivery syringe and needle for placing particle suspensions and removing vehicle fluid
WO2009124096A1 (en)2008-03-312009-10-08Altea Therapeutics CorporationPermeant delivery system and methods for use thereof
US20090258069A1 (en)2008-04-152009-10-15John BurnierDelivery of LFA-1 antagonists to the gastrointestinal system
US20090259212A1 (en)2008-04-102009-10-15Sabbah Hani NApparatus and method for controlled depth of injection into myocardial tissue
US20090263346A1 (en)2006-12-052009-10-22David TaftSystems and methods for delivery of drugs
WO2009134929A2 (en)2008-05-012009-11-05Revalesio CorporationCompositions and methods for treating digestive disorders
US7615141B2 (en)2003-10-032009-11-10University Of WashingtonElectrochemical micromanufacturing system and method
WO2009137780A2 (en)2008-05-082009-11-12Replenish Pumps, LlcImplantable pumps and cannulas therefor
WO2009137777A2 (en)2008-05-082009-11-12Replenish Pumps, LlcImplantable drug-delivery devices, and apparatus and methods for filling the devices
US20090280470A1 (en)2006-02-242009-11-12Rosetta Inpharmatics LlcExtraction and diagnostic fluid devices, systems and methods of use
USD604836S1 (en)*2008-03-072009-11-24Becton, Dickinson And CompanySafety blood collection assembly
US20090306025A1 (en)2008-05-302009-12-10Fairfield Clinical Trials, LlcMethod and composition for skin inflammation and discoloration
US20090318545A1 (en)2008-06-092009-12-24Cornell Reasearch Foundation, Inc.Mast cell inhibition in diseases of the retina and vitreous
US20090326489A1 (en)2006-12-162009-12-31Arnd KensyApplicator for a water jet separating apparatus
US20090326448A1 (en)2006-04-182009-12-31Pingan HuoSterile Drug-Mixing Syringe
US20100004189A1 (en)2007-10-252010-01-07Revalesio CorporationCompositions and methods for treating cystic fibrosis
US20100010452A1 (en)2007-01-092010-01-14Fovea PharmaceuticalsApparatus for intra-ocular injection
US20100008997A1 (en)2007-10-252010-01-14Revalesio CorporationCompositions and methods for treating asthma and other lung disorders
US20100009008A1 (en)2007-10-252010-01-14Revalesio CorporationBacteriostatic or bacteriocidal compositions and methods
US20100015157A1 (en)2004-10-202010-01-21Genentech, Inc.Antibody formulations
WO2010008424A2 (en)2008-04-042010-01-21Novartis AgAerosolization device
US20100016786A1 (en)2008-07-212010-01-21Arstasis, Inc.Devices, methods, and kits for forming tracts in tissue
US20100011888A1 (en)2006-07-192010-01-21Janusz PawliszynMethod and device to extract components contained in a fluid
US20100015158A1 (en)2008-07-182010-01-21Allergan, Inc.Method for treating atrophic age related macular degeneration
US20100022943A1 (en)2008-07-252010-01-28Medtronic Vascular, Inc.Hydrodynamic Thrombectomy Catheter
US20100023033A1 (en)2008-07-252010-01-28Medtronic Vescular, Inc.Hydrodynamic Thrombectomy Catheter
US20100028443A1 (en)2007-10-252010-02-04Revalesio CorporationCompositions and methods for treating inflammation
US20100030136A1 (en)2006-10-162010-02-04Bruno DacquayOphthalmic Injection Device Including Dosage Control Device
US20100028442A1 (en)2006-10-252010-02-04Revalesio CorporationMethods of therapeutic treatment of eyes
USD609804S1 (en)*2008-11-202010-02-09Nipro CorporationBlood sampling needle
US20100034870A1 (en)2008-04-302010-02-11QLT. Plug Delivery, Inc.Composite lacrimal insert and related methods
WO2010021993A1 (en)2008-08-192010-02-25Cytori Therapeutics, Inc.Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
US7678078B1 (en)2008-10-212010-03-16KMG Pharma LLCIntravitreal injection device, system and method
US7699820B1 (en)2008-08-122010-04-20French Ronald JDevice for irrigating the ear canal
US20100100054A1 (en)2008-10-212010-04-22Michel CormierIntravitreal injection device and system
US20100114017A1 (en)2002-07-232010-05-06Reverse Medical CorporationSystems and methods for removing obstructive matter from body lumens and treating vascular defects
US20100114309A1 (en)2006-12-262010-05-06De Juan Jr EugeneDrug delivery implants for inhibition of optical defects
WO2010062628A1 (en)2008-10-272010-06-03Revalesio CorporationCompositions and methods for treating asthma and other lung disorders
WO2010066714A1 (en)2008-12-092010-06-17Pari Pharma GmbhAerosol therapy device
US20100158980A1 (en)2008-12-182010-06-24Casey KopczynskiDrug delivery devices for delivery of therapeutic agents
US20100168535A1 (en)2006-04-122010-07-01Mark Ries RobinsonMethods and apparatuses related to blood analyte measurement system
WO2010078063A1 (en)2009-01-022010-07-08Alcon Research, Ltd.In-situ refillable ophthalmic implant
US20100185205A1 (en)2009-01-162010-07-22Allergan, Inc.Interocular injector
US20100191176A1 (en)2009-01-232010-07-29Iscience Interventional CorporationSubretinal access device
US20100189765A1 (en)2008-11-262010-07-29Erickson Signe RImplantable ocular drug delivery device and methods
US20100197512A1 (en)2008-07-112010-08-05IntellicytMulti-Sample Particle Analyzer and Method for High Throughput Screening
WO2010088548A1 (en)2009-01-292010-08-05Forsight Labs, LlcPosterior segment drug delivery
US20100211041A1 (en)2007-07-302010-08-19Masayoshi OmoriApparatus for separating and storing blood components
WO2010093945A2 (en)2009-02-132010-08-19Glaukos CorporationUveoscleral drug delivery implant and methods for implanting the same
WO2010095940A2 (en)2009-02-202010-08-26To-Bbb Holding B.V.Glutathione-based drug delivery system
US20100221309A1 (en)2001-10-122010-09-02Monosol Rx, LlcFilm compositions for delivery of actives
US20100227904A1 (en)2009-03-032010-09-09Alcon Research, Ltd.Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
US20100223979A1 (en)2009-03-042010-09-09University Of South CarolinaSystems and Methods for Measurement of Gas Permeation Through Polymer Films
US20100256597A1 (en)2006-05-022010-10-07Emory UniversityMethods and Devices for Drug Delivery to Ocular Tissue Using Microneedle
WO2010126908A1 (en)2009-04-272010-11-04Revalesio CorporationCompositions and methods for treating insulin resistance and diabetes mellitus
WO2010125416A1 (en)2009-04-272010-11-04Raouf RekikDrug delivery to the anterior and posterior segments of the eye
US20100286791A1 (en)2006-11-212010-11-11Goldsmith David SIntegrated system for the ballistic and nonballistic infixion and retrieval of implants
WO2010135369A1 (en)2009-05-182010-11-25Dose Medical CorporationDrug eluting ocular implant
US20100297120A1 (en)2007-05-292010-11-25Angiochem Inc.Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US20100297193A1 (en)2006-10-252010-11-25Revalesio CorporationMethods of therapeutic treatment of eyes
US20100303918A1 (en)2007-10-252010-12-02Revalesio CorporationCompositions and methods for treating asthma and other lung disorders
US20100303917A1 (en)2007-10-252010-12-02Revalesio CorporationCompositions and methods for treating cystic fibrosis
US20100310665A1 (en)2007-10-252010-12-09Revalesio CorporationBacteriostatic or bacteriocidal compositions and methods
WO2010141729A1 (en)2009-06-032010-12-09Forsight Labs, LlcAnterior segment drug delivery
US20100310664A1 (en)2009-04-272010-12-09Revalesio CorporationCompositions and methods for treating insulin resistance and diabetes mellitus
US20100316723A1 (en)2007-10-252010-12-16Revalesio CorporationCompositions and methods for treating inflammation
US20110009571A1 (en)2006-12-052011-01-13David TaftSystems and methods for delivery of materials
WO2011008896A2 (en)2009-07-142011-01-20Board Of Regents, The University Of Texas SystemTherapeutic methods using controlled delivery devices having zero order kinetics
US20110034448A1 (en)2004-04-302011-02-10Allergan, Inc.Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US20110033933A1 (en)2009-07-152011-02-10Morteza GharibMethod applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves
WO2011028850A1 (en)2009-09-012011-03-10Northwestern UniversityDelivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers
US20110071492A1 (en)*2009-09-182011-03-24Becton, Dickinson And CompanyHub assembly having a hidden needle for a drug delivery pen
WO2011034627A2 (en)2009-09-212011-03-24Harvard Bioscience, Inc.Methods and apparatus for introducing cells at a tissue site
US7914442B1 (en)1999-03-012011-03-29Gazdzinski Robert FEndoscopic smart probe and method
US20110081384A1 (en)2006-10-252011-04-07Revalesio CorporationMethods of wound care and treatment
US20110117083A1 (en)2009-08-142011-05-19Genentech, Inc.Biological markers for monitoring patient response to vegf antagonists
US20110125178A1 (en)2009-05-152011-05-26Michael DrewsDevices, methods and kits for forming tracts in tissue
CN102112076A (en)2007-09-072011-06-29Qlt栓塞输送公司Lacrimal implants and related methods
WO2011079232A1 (en)2009-12-232011-06-30Psivida Us, Inc.Sustained release delivery devices
US7973068B2 (en)1998-10-202011-07-05Omeros CorporationArthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US20110190723A1 (en)2006-04-122011-08-04Fangrow Thomas FPressure-regulating vials and containers
US20110281901A1 (en)2010-05-052011-11-17Glaxo Wellcome Manufacturing Pte Ltd.Pharmaceutical compositions and methods of making same
USD651308S1 (en)*2008-03-072011-12-27Becton, Dickinson And CompanySafety blood collection assembly
US20120022459A1 (en)*2009-02-062012-01-26Horvath JoshuaPen needle to facilitate manipulation by users having physical or visual impairment
US20120029469A1 (en)*2009-02-062012-02-02Becton, Dickerson and CompanyLubricated pen needle
WO2012019136A2 (en)2010-08-052012-02-09Forsight Vision 4, Inc.Injector apparatus and method for drug delivery
WO2012019047A2 (en)2010-08-052012-02-09Forsight Vision4, Inc.Subconjunctival implant for posterior segment drug delivery
US20120095439A1 (en)2010-01-292012-04-19De Juan Jr EugeneImplantable therapeutic device
WO2012065006A2 (en)2010-11-112012-05-18Forsight Vision4, Inc.Methods and apparatus to determine porous structures for drug delivery
US20120179115A1 (en)*2009-09-182012-07-12Horvath JoshuaSeparable hub post of pen needle
US20120184905A1 (en)2010-02-222012-07-19Microsert Ltd.Slow release liquid drug delivery device
USD667951S1 (en)*2010-07-282012-09-25Owen Mumford LimitedTorque limiting needle cap
US20120296423A1 (en)2011-05-162012-11-22Sean CaffeyFilling and implanting accommodative intraocular lenses
WO2013003620A2 (en)2011-06-282013-01-03Forsight Vision4, Inc.Diagnostic methods and apparatus
WO2013022801A1 (en)2011-08-052013-02-14Forsight Vision4, Inc.Small molecule delivery with implantable therapeutic device
WO2013040247A2 (en)2011-09-162013-03-21Forsight Vision4, Inc.Fluid exchange apparatus and methods
USD690008S1 (en)*2012-11-062013-09-17Shanghai Jinta Medical Apparatus Co., Ltd.Safety medical lancet
WO2013151904A1 (en)2012-04-022013-10-10Ocuject, LlcIntraocular delivery devices and methods therefor
US20130274691A1 (en)2010-08-052013-10-17Forsight Vision4, Inc.Combined drug delivery methods and apparatus
US20130324942A1 (en)2010-08-052013-12-05Eugene de Juan, Jr.Implantable therapeutic device
US20130338564A1 (en)2011-12-122013-12-19Alcon Research, Ltd.Glaucoma drainage devices including vario-stable valves and associated systems and methods
US20140031769A1 (en)2010-11-192014-01-30Forsight Vision4, Inc.Therapeutic agent formulations for implanted devices
US20140276482A1 (en)2013-03-142014-09-18Forsight Vision4, Inc.Systems for Sustained Intraocular Delivery of Low Solubility Compounds from a Port Delivery System Implant
US20140296800A1 (en)2013-03-282014-10-02Forsight Vision4, Inc.Ophthalmic Implant for Delivering Therapeutic Substances
US20150080846A1 (en)2012-02-032015-03-19Forsight Vision4, Inc.Insertion and removal methods and apparatus for therapeutic devices
CN204600878U (en)2015-03-172015-09-02同济大学附属第十人民医院A kind of injection needle device
US20160038488A1 (en)2014-08-082016-02-11Forsight Vision4, Inc.Stable and Soluble Formulations of Receptor Tyrosine Kinase Inhibitors, and Methods of Preparation Thereof
US20160128867A1 (en)2014-11-102016-05-12Forsight Vision4, Inc.Expandable Drug Delivery Devices and Methods of Use
CN105979985A (en)2013-10-072016-09-28奥库杰克特有限责任公司Intraocular delivery devices and methods therefor
US20160302965A1 (en)2013-12-062016-10-20Forsight Vision4, Inc.Implantable therapeutic devices
CN106413642A (en)2014-04-232017-02-15塞罗斯医学有限责任公司Vacuum-assisted drug delivery device
US20170087016A1 (en)2015-09-302017-03-30Camras Vision, Inc.Method and apparatus for reducing intraocular pressure
WO2017087902A1 (en)2015-11-202017-05-26Forsight Vision4, Inc.Porous structures for extended release drug delivery devices
US20170165108A1 (en)2014-07-152017-06-15Forsight Vision4, Inc.Ocular implant delivery device and method
USD823458S1 (en)*2016-07-052018-07-17Retractable Technologies, Inc.Blood collection tube holder
USD823457S1 (en)*2012-12-142018-07-17Retractable Technologies, Inc.Blood collection tube holder with offset needle retraction chamber and frontal attachment
US20190117454A1 (en)2016-04-052019-04-25Forsight Vision4, Inc.Implantable Ocular Drug Delivery Devices
TWM577313U (en)2019-01-142019-05-01大學光學科技股份有限公司Cataract crystal nucleus breaking device
USD853563S1 (en)2017-08-232019-07-09Jjgc Indústria E Comércio De Materiais Dentários S.A.Star shaped driver
US20200337897A1 (en)2017-11-212020-10-29Forsight Vision4, Inc.Fluid exchange apparatus for expandable port delivery system and methods of use
USD901683S1 (en)2017-10-272020-11-10Glaukos CorporationImplant delivery apparatus
USD911518S1 (en)*2019-07-312021-02-23Shali Medical (Suzhou) Inc.Needle shield
JP1739057S (en)*2022-01-242023-03-15 fluid changer
US20230181829A1 (en)*2020-08-142023-06-15pHi-Tech Animal Health Technologies Ltd.Injection apparatus and method for aquatic species

Patent Citations (665)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US134128A (en)*1872-12-24Improvement in blasting-fuses
US170342A (en)*1875-11-23Improvement in attachments for dental engines
CA134128A (en)*1911-02-271911-06-27William H. West Jr.Window pane fastener
CA170342A (en)*1916-02-111916-06-20Melvin L. SeveryOrthopedic device
US1747814A (en)1927-10-031930-02-18Gulf Production CompanyAutomatic switcher device for oil-storage tanks
US2585815A (en)1947-01-161952-02-12Mclintock Duncan MenziesInjection syringe
US2564977A (en)1949-01-191951-08-21Hu Quang HsiMedical injecting apparatus
US2646042A (en)1951-05-181953-07-21Hu Quang HsiMedical apparatus
US2886497A (en)1957-04-121959-05-12United States Steel CorpMethod for determining the permeability of steel to hydrogen
US3232117A (en)1962-09-141966-02-01Roger Gilmont Instr IncMicrometer buret
US3416530A (en)1966-03-021968-12-17Richard A. NessEyeball medication dispensing tablet
US3612089A (en)1968-10-281971-10-12Torit CorpVacuum reactivator
US3618604A (en)1969-06-091971-11-09Alza CorpOcular insert
US3641237A (en)1970-09-301972-02-08Nat Patent Dev CorpZero order release constant elution rate drug dosage
US4034756A (en)1971-01-131977-07-12Alza CorporationOsmotically driven fluid dispenser
US3831583A (en)1971-03-051974-08-27Univ CaliforniaImplantable bulb for inflation of surgical implements
US3734095A (en)1971-05-211973-05-22L SantomieriFluid infusion
US3995635A (en)1971-09-091976-12-07Alza CorporationOcular insert
US3828777A (en)1971-11-081974-08-13Alza CorpMicroporous ocular device
US3845201A (en)1972-04-241974-10-29S LoucasSolid state ophthalmic medication delivery method
US3916899A (en)1973-04-251975-11-04Alza CorpOsmotic dispensing device with maximum and minimum sizes for the passageway
US3914402A (en)1973-06-141975-10-21Alza CorpOphthalmic dosage form, for releasing medication over time
US4179497A (en)1973-12-171979-12-18Merck & Co., Inc.Solid state ophthalmic medication
US3902495A (en)1974-01-281975-09-02Cavitron CorpFlow control system
US3961628A (en)1974-04-101976-06-08Alza CorporationOcular drug dispensing system
US3949748A (en)1974-09-261976-04-13Oscar MalminInjection syringe having aspirating and metering capabilities
US3949750A (en)1974-10-071976-04-13Freeman Jerre MPunctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US3926188A (en)1974-11-141975-12-16Alza CorpLaminated drug dispenser
US4135514A (en)1974-12-231979-01-23Alza CorporationOsmotic releasing system for administering ophthalmic drug to eye of animal
US4014335A (en)1975-04-211977-03-29Alza CorporationOcular drug delivery device
US4343787A (en)1975-07-291982-08-10Merck & Co., Inc.Shaped ophthalmic inserts for treating dry eye syndrome
US3977404A (en)1975-09-081976-08-31Alza CorporationOsmotic device having microporous reservoir
US4034758A (en)1975-09-081977-07-12Alza CorporationOsmotic therapeutic system for administering medicament
US4014333A (en)1975-09-221977-03-29Mcintyre David JInstrument for aspirating and irrigating during ophthalmic surgery
US4077407A (en)1975-11-241978-03-07Alza CorporationOsmotic devices having composite walls
US4014334A (en)1976-02-021977-03-29Alza CorporationLaminated osmotic system for dispensing beneficial agent
US4008719A (en)1976-02-021977-02-22Alza CorporationOsmotic system having laminar arrangement for programming delivery of active agent
US4111203A (en)1976-11-221978-09-05Alza CorporationOsmotic system with means for improving delivery kinetics of system
US4111201A (en)1976-11-221978-09-05Alza CorporationOsmotic system for delivering selected beneficial agents having varying degrees of solubility
US4256108A (en)1977-04-071981-03-17Alza CorporationMicroporous-semipermeable laminated osmotic system
US4160452A (en)1977-04-071979-07-10Alza CorporationOsmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4164559A (en)1977-09-211979-08-14Cornell Research Foundation, Inc.Collagen drug delivery device
US4186184A (en)1977-12-271980-01-29Alza CorporationSelective administration of drug with ocular therapeutic system
US4220153A (en)1978-05-081980-09-02Pfizer Inc.Controlled release delivery system
US4220152A (en)1978-05-081980-09-02Pfizer Inc.Delivery system
US4200098A (en)1978-10-231980-04-29Alza CorporationOsmotic system with distribution zone for dispensing beneficial agent
US4298000A (en)1978-11-081981-11-03Minnesota Mining And Manufacturing CompanyFluid dispensing device
US4300557A (en)1980-01-071981-11-17The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesMethod for treating intraocular malignancies
EP0033042B1 (en)1980-01-281984-08-22Merck & Co. Inc.Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors
US4309776A (en)1980-05-131982-01-12Ramon BerguerIntravascular implantation device and method of using the same
US4326525A (en)1980-10-141982-04-27Alza CorporationOsmotic device that improves delivery properties of agent in situ
US4327725A (en)1980-11-251982-05-04Alza CorporationOsmotic device with hydrogel driving member
US4484922A (en)1981-06-251984-11-27Rosenwald Peter LOccular device
US4439198A (en)1981-07-091984-03-27University Of Illinois FoundationBiodegradable ocular insert for controlled delivery of ophthalmic medication
US4730013A (en)1981-10-081988-03-08Merck & Co., Inc.Biosoluble ocular insert
US4439196A (en)1982-03-181984-03-27Merck & Co., Inc.Osmotic drug delivery system
US4475916A (en)1982-03-181984-10-09Merck & Co., Inc.Osmotic drug delivery system
US4519801A (en)1982-07-121985-05-28Alza CorporationOsmotic device with wall comprising cellulose ether and permeability enhancer
US4673405A (en)1983-03-041987-06-16Alza CorporationOsmotic system with instant drug availability
US4883459A (en)1983-07-291989-11-28Reynaldo CalderonRetrograde perfusion
US4774091A (en)1983-10-141988-09-27Sumitomo Pharmaceuticals Company, Ltd.Long-term sustained-release preparation
US4627850A (en)1983-11-021986-12-09Alza CorporationOsmotic capsule
US4777049A (en)1983-12-011988-10-11Alza CorporationConstant release system with pulsed release
US4634418A (en)1984-04-061987-01-06Binder Perry SHydrogel seton
US4851228A (en)1984-06-201989-07-25Merck & Co., Inc.Multiparticulate controlled porosity osmotic
US4634427A (en)1984-09-041987-01-06American Hospital Supply CompanyImplantable demand medication delivery assembly
US5053030A (en)1984-11-071991-10-01Herrick Robert SIntracanalicular implant for horizontal canalicular blockade treatment of the eye
US5049142A (en)1984-11-071991-09-17Herrick Robert SIntracanalicular implant for horizontal canalicular blockade treatment of the eye
US4712550A (en)1985-04-081987-12-15Sinnett Kevin BRetinal tack
US4609374A (en)1985-04-221986-09-02Alza CorporationOsmotic device comprising means for governing initial time of agent release therefrom
US4693886A (en)1985-04-221987-09-15Alza CorporationOsmotic device with inert core
US4737150A (en)1985-05-101988-04-12Intermedicat GmbhTwo-cannula syringe
US4781675A (en)1985-11-271988-11-01White Thomas CInfusion cannula
EP0228185A1 (en)1985-11-271987-07-08Thomas C. WhiteTissue-implantable fluid-dissipating device
US4959217A (en)1986-05-221990-09-25Syntex (U.S.A.) Inc.Delayed/sustained release of macromolecules
US5322691A (en)1986-10-021994-06-21Sohrab DarougarOcular insert with anchoring protrusions
US5147647A (en)1986-10-021992-09-15Sohrab DarougarOcular insert for the fornix
US4863457A (en)1986-11-241989-09-05Lee David ADrug delivery device
WO1988004573A1 (en)1986-12-231988-06-30The Liposome Company, Inc.Liposome preparation and antibiotic
EP0498471A2 (en)1986-12-231992-08-12The Liposome Company, Inc.Liposomes comprising a guanidino aminoglycoside
EP0500143A2 (en)1986-12-231992-08-26The Liposome Company, Inc.Pharmaceutical composition comprising an aminoglycoside phosphate
EP0295248A1 (en)1986-12-231988-12-21Liposome Co IncLiposome preparation and antibiotic.
JPH01149716A (en)1987-10-261989-06-12Alza CorpDrug administration system
US4853229A (en)1987-10-261989-08-01Alza CorporationMethod for adminstering tiny pills
JPH01197429A (en)1988-01-301989-08-09Olympus Optical Co LtdCeramics impregnated with medicament liquid
US4865846A (en)1988-06-031989-09-12Kaufman Herbert EDrug delivery system
US5174999A (en)1988-12-131992-12-29Alza CorporationDelivery system comprising fluid ingress and drug egress
WO1990007545A2 (en)1988-12-301990-07-12Anderson David MStabilized microporous materials and hydrogel materials
US5141748A (en)1989-02-171992-08-25Hoffmann-La Roche, Inc.Implant drug delivery device
US5098443A (en)1989-03-231992-03-24University Of MiamiMethod of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US4979938A (en)1989-05-111990-12-25Iomed, Inc.Method of iontophoretically treating acne, furuncles and like skin disorders
US5817075A (en)1989-08-141998-10-06Photogenesis, Inc.Method for preparation and transplantation of planar implants and surgical instrument therefor
US5164188A (en)1989-11-221992-11-17Visionex, Inc.Biodegradable ocular implants
US5324518A (en)1989-12-081994-06-28Biosynthesis, Inc.Implantable structure for containing substances for delivery to a body
US5171270A (en)1990-03-291992-12-15Herrick Robert SCanalicular implant having a collapsible flared section and method
US5413572A (en)1990-04-021995-05-09Alza CorporationOsmotic dosage system for liquid drug delivery
US5128145A (en)1990-06-131992-07-07Alza CorporationDosage form for Parkinson's disease, spasticity and muscle spasms
US5238687A (en)1990-07-111993-08-24Alza CorporationDelivery device with a protective sleeve
US5084021A (en)1990-11-021992-01-28Baldwin Brian EPatient controlled infusion apparatus and method
US5273530A (en)1990-11-141993-12-28The University Of RochesterIntraretinal delivery and withdrawal instruments
US5378475A (en)1991-02-211995-01-03University Of Kentucky Research FoundationSustained release drug delivery devices
US5364343A (en)1991-03-061994-11-15D.D. S.R.L.Irrigation device for use in ear canals for therapeutic or hygienic purposes
US5562915A (en)1991-04-051996-10-08Eli Lilly And CompanySustained release capsule and formulations
US5277912A (en)1991-04-051994-01-11Eli Lilly And CompanySustained release capsule and formulations
US5334189A (en)1991-06-031994-08-02Wade Stephen EDevice for controlled diffusion of a chemical substance
US5282829A (en)1991-08-151994-02-01United States Surgical CorporationHollow body implants
US5830546A (en)1991-10-031998-11-03Holvis Holzstoff S.A.Reservoir system for prolonged diffusion of an active principle
US5681572A (en)1991-10-181997-10-28Seare, Jr.; William J.Porous material product and process
US5300114A (en)1992-05-041994-04-05Allergan, Inc.Subconjunctival implants for ocular drug delivery
US5476511A (en)1992-05-041995-12-19Allergan, Inc.Subconjunctival implants for ocular drug delivery
US5322504A (en)1992-05-071994-06-21United States Surgical CorporationMethod and apparatus for tissue excision and removal by fluid jet
US7026329B2 (en)1992-09-212006-04-11Albert Einstein College Of Medicine Of Yeshiva UniversityMethod of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5336175A (en)1992-10-291994-08-09Mames Robert NMethod for the treatment of retinal detachments
WO1994024969A1 (en)1993-04-301994-11-10Allergan, Inc.Apparatus and method for the removal of adherent viscoelastic
US5358473A (en)1993-04-301994-10-25Mitchell Paul GApparatus and method for the removal of adherent viscoelastic material
US5443505A (en)1993-11-151995-08-22Oculex Pharmaceuticals, Inc.Biocompatible ocular implants
US5824072A (en)1993-11-151998-10-20Oculex Pharmaceuticals, Inc.Biocompatible ocular implants
US5766242A (en)1993-11-151998-06-16Oculex Pharmaceuticals, Inc.Biocompatible ocular implants
EP0671165A2 (en)1994-02-091995-09-13Collagen CorporationCollagen-based injectable drug delivery system and its use
US5807581A (en)1994-02-091998-09-15Collagen CorporationCollagen-based injectable drug delivery system and its use
US5985328A (en)1994-03-071999-11-16Regents Of The University Of CaliforniaMicromachined porous membranes with bulk support
US5770076A (en)1994-03-071998-06-23The Regents Of The University Of CaliforniaMicromachined capsules having porous membranes and bulk supports
US5578042A (en)1994-03-141996-11-26Cumming; J. StuartOphthalmic kit and method for lens insertion
US5466233A (en)1994-04-251995-11-14Escalon Ophthalmics, Inc.Tack for intraocular drug delivery and method for inserting and removing same
WO1995028984A1 (en)1994-04-251995-11-02Escalon Ophthalmics, Inc.Tack for intraocular drug delivery and method for inserting and removing same
US5476448A (en)1994-10-191995-12-19Urich; AlexApparatus for suppressing a vacuum surge in eye surgery
US5916584A (en)1994-10-251999-06-29Daratech Proprietary LimitedControlled release container with core and outer shell
US5836935A (en)1994-11-101998-11-17Ashton; PaulImplantable refillable controlled release device to deliver drugs directly to an internal portion of the body
US5725493A (en)1994-12-121998-03-10Avery; Robert LoganIntravitreal medicine delivery
US5830173A (en)1994-12-121998-11-03Avery; Robert LoganIntravitreal medicine delivery
US6251090B1 (en)1994-12-122001-06-26Robert Logan AveryIntravitreal medicine delivery
US5792099A (en)1995-02-141998-08-11Decamp; DennisSyringe and cannula for insertion of viscoelastic material into an eye and method of using same
US5554132A (en)1995-03-301996-09-10Abbott LaboratoriesHand grip for use with syringe
US5674193A (en)1995-04-051997-10-07Hayes; Lili L.Oral/nasal-gastric drainage kit
US5868697A (en)1995-05-141999-02-09Optonol Ltd.Intraocular implant
US6685940B2 (en)1995-07-272004-02-03Genentech, Inc.Protein formulation
US6001386A (en)1995-09-271999-12-14University Of Kentucky Research FoundationImplantable controlled release device to deliver drugs directly to an internal portion of the body
US5773019A (en)1995-09-271998-06-30The University Of Kentucky Research FoundationImplantable controlled release device to deliver drugs directly to an internal portion of the body
US20040011651A1 (en)1996-01-312004-01-22Board Of Regents, The University Of Texas SystemMethod and apparatus for fractionation using conventional dielectrophoresis and field flow fractionation
WO1997029850A1 (en)1996-02-151997-08-21Nomix-Chipman LimitedSpray gun
US20090005864A1 (en)1996-03-182009-01-01Eggleston Harry CModular intraocular implant
US5951512A (en)1996-05-281999-09-14Horizon Medical Products, Inc.Infusion port with modified drug reservoir
US6123861A (en)1996-07-022000-09-26Massachusetts Institute Of TechnologyFabrication of microchip drug delivery devices
US5797898A (en)1996-07-021998-08-25Massachusetts Institute Of TechnologyMicrochip drug delivery devices
US5928662A (en)1996-07-311999-07-27Phillips; Andrew F.Ocular drug delivery device
US20020049389A1 (en)1996-09-042002-04-25Abreu Marcio MarcNoninvasive measurement of chemical substances
EP0944658B1 (en)1996-12-132003-06-25Novartis AGPorous polyorganosiloxane polymers
US6663668B1 (en)1996-12-132003-12-16Novartis AgHydratable siloxane comprising porous polymers
WO1998025982A1 (en)1996-12-131998-06-18Novartis AgPorous polyorganosiloxane polymers
US5755684A (en)1996-12-201998-05-26Chen; Jen-YieVolume homeostatic fluid-fluid exchanger
US5972369A (en)1997-03-311999-10-26Alza CorporationDiffusional implantable delivery system
WO1998043611A1 (en)1997-03-311998-10-08Alza CorporationDiffusional implantable delivery system
JP2001518880A (en)1997-03-312001-10-16アルザ・コーポレイション Diffusion injection supply system
US7476510B2 (en)1997-05-292009-01-13Cellomics, Inc.Miniaturized cell array methods and apparatus for cell-based screening
US5968008A (en)1997-08-041999-10-19Grams; Guenter A.Cannula with parallel channels and sliding sheath
WO1999011244A1 (en)1997-08-281999-03-11Control Delivery Systems, Inc.Sustained release drug delivery devices
US5902598A (en)1997-08-281999-05-11Control Delivery Systems, Inc.Sustained release drug delivery devices
US6331523B1 (en)1998-03-122001-12-18Genentech, Inc.Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5
US6196993B1 (en)1998-04-202001-03-06Eyelab Group, LlcOphthalmic insert and method for sustained release of medication to the eye
US6695821B1 (en)1998-06-172004-02-24Raymond N. SjaardaSurgical infusion tool with flow diffuser
US6605066B1 (en)1998-09-182003-08-12Imedex BiomateriauxDevice for forming and delivering a mixture
US7973068B2 (en)1998-10-202011-07-05Omeros CorporationArthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US6620139B1 (en)1998-12-142003-09-16Tre Esse Progettazione Biomedica S.R.L.Catheter system for performing intramyocardiac therapeutic treatment
US20040024371A1 (en)1998-12-142004-02-05Gianni PlicchiCatheter system for performing intramyocardiac therapeutic treatment
US6740077B1 (en)1999-02-182004-05-25Alcove Surfaces GmbhImplant with permeable element
WO2000048660A1 (en)1999-02-182000-08-24Alcove Surfaces GmbhImplant
US7914442B1 (en)1999-03-012011-03-29Gazdzinski Robert FEndoscopic smart probe and method
US6395300B1 (en)1999-05-272002-05-28Acusphere, Inc.Porous drug matrices and methods of manufacture thereof
US6932983B1 (en)1999-05-272005-08-23Acusphere, Inc.Porous drug matrices and methods of manufacture thereof
US6472162B1 (en)1999-06-042002-10-29Thermogenesis Corp.Method for preparing thrombin for use in a biological glue
US6420399B1 (en)1999-06-182002-07-16Alcon Manufacturing, Ltd.Topical ophthalmic mast cell stabilizers for treating allergic eye disease
WO2001026714A1 (en)1999-10-122001-04-19Durect CorporationRegulation of drug delivery through flow diversion
US6468264B1 (en)1999-10-122002-10-22Durect CorporationClosed exchange system
US6413540B1 (en)1999-10-212002-07-02Alcon Universal Ltd.Drug delivery device
US20030003129A1 (en)1999-10-212003-01-02Yoseph YaacobiOphthalmic drug delivery device
US6669950B2 (en)1999-10-212003-12-30Alcon, Inc.Ophthalmic drug delivery device
US6416777B1 (en)1999-10-212002-07-09Alcon Universal Ltd.Ophthalmic drug delivery device
US20050112175A1 (en)1999-10-212005-05-26Yoseph YaacobiDrug delivery device
US20040131655A1 (en)1999-10-212004-07-08Yoseph YaacobiOphthalmic drug delivery device
US20040131654A1 (en)1999-10-212004-07-08Yoseph YaacobiOphthalmic drug delivery device
US6331313B1 (en)1999-10-222001-12-18Oculex Pharmaceticals, Inc.Controlled-release biocompatible ocular drug delivery implant devices and methods
US20080161741A1 (en)2000-01-122008-07-03Becton, Dickinson And CompanyOcular implant and methods for making and using same
US20050119737A1 (en)2000-01-122005-06-02Bene Eric A.Ocular implant and methods for making and using same
WO2001050943A2 (en)2000-01-122001-07-19Becton, Dickinson And CompanySystems and methods for reducing intraocular pressure
US7141023B2 (en)2000-02-252006-11-28Disetronic Licensing AgMicro perfusion device comprising a collecting container
US20030047011A1 (en)2000-02-252003-03-13Ulrich DiermannMicro perfusion device comprising a collecting container
US7077848B1 (en)2000-03-112006-07-18John Hopkins UniversitySutureless occular surgical methods and instruments for use in such methods
WO2001068016A2 (en)2000-03-112001-09-20Johns Hopkins UniversitySutureless ocular surgical methods and instruments
US20030005945A1 (en)2000-03-132003-01-09Hiroyuki OnishiMethod for surface-treatment, surface-treated article and device for surface treatment
US7141152B2 (en)2000-03-162006-11-28Le Febre David AAnalyte species separation system
US20050049578A1 (en)2000-04-142005-03-03Hosheng TuImplantable ocular pump to reduce intraocular pressure
US6375972B1 (en)2000-04-262002-04-23Control Delivery Systems, Inc.Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
USRE40755E1 (en)*2000-04-282009-06-23Mdc Investment Holdings, Inc.Needle-bearing medical device
US6719750B2 (en)2000-08-302004-04-13The Johns Hopkins UniversityDevices for intraocular drug delivery
US20020026176A1 (en)2000-08-302002-02-28Varner Signe EricksonDevices for intraocular drug delivery
EP1337284B1 (en)2000-09-062007-12-05Alcon Inc.Switchable tackiness coating compositions for ophthalmic implants
US6303290B1 (en)2000-09-132001-10-16The Trustees Of The University Of PennsylvaniaEncapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
US6869412B2 (en)2000-11-132005-03-22Edward Allan RossMethod and device for intravascular plasma fluid removal
US6756049B2 (en)2000-12-292004-06-29Bausch & Lomb IncorporatedSustained release drug delivery devices
US20020110591A1 (en)2000-12-292002-08-15Brubaker Michael J.Sustained release drug delivery devices
WO2002053128A2 (en)2001-01-032002-07-11Bausch & Lomb IncorporatedSustained release drug delivery devices with multiple agents
JP2004516889A (en)2001-01-032004-06-10ボシュ・アンド・ロム・インコーポレイテッド Sustained release drug delivery device with multiple drugs
US20020086051A1 (en)2001-01-032002-07-04Santos ViscasillasSustained release drug delivery devices with coated drug cores
US6756058B2 (en)2001-01-032004-06-29Bausch & Lomb IncorporatedSustained release drug delivery devices with multiple agents
US20020110592A1 (en)2001-01-032002-08-15Brubaker Michael J.Sustained release drug delivery devices with multiple agents
US20020106395A1 (en)2001-01-032002-08-08Brubaker Michael J.Sustained release drug delivery devices with prefabricated permeable plugs
US20030212383A1 (en)2001-01-052003-11-13Dana CoteSystem and methods for reducing intraocular pressure
US6976982B2 (en)2001-01-092005-12-20Microchips, Inc.Flexible microchip devices for ophthalmic and other applications
US20040171997A1 (en)2001-01-242004-09-02Wilson Jon S.Double-y-shaped multi-lumen catheter with selectively attachable hubs
US20020110635A1 (en)2001-01-262002-08-15Brubaker Michael J.Process for the production of sustained release drug delivery devices
US7181287B2 (en)2001-02-132007-02-20Second Sight Medical Products, Inc.Implantable drug delivery device
US20040247487A1 (en)2001-03-022004-12-09Pierre CommerconMeans for extracting products to be analysed and applications thereof in diagnosis and analysis
US6713081B2 (en)2001-03-152004-03-30The United States Of America As Represented By The Department Of Health And Human ServicesOcular therapeutic agent delivery devices and methods for making and using such devices
US20020165522A1 (en)2001-05-032002-11-07Jorgen HolmenMethod for use in cataract surgery
US20020188244A1 (en)2001-05-312002-12-12Alan SmithDevice and method for colonic lavage
US20170172794A1 (en)2001-06-122017-06-22The Johns Hopkins UniversityReservoir Device for Intraocular Drug Delivery
US20030014036A1 (en)2001-06-122003-01-16Varner Signe EricksonReservoir device for intraocular drug delivery
WO2002100318A2 (en)2001-06-122002-12-19Johns Hopkins University School Of MedicineReservoir device for intraocular drug delivery
US20130304031A1 (en)2001-06-122013-11-14The Johns Hopkins University School Of MedicineReservoir Device for Intraocular Drug Delivery
US7883717B2 (en)2001-06-122011-02-08Johns Hopkins UniversityReservoir device for intraocular drug delivery
US20140243795A1 (en)2001-06-122014-08-28Johns Hopkins University School Of MedicineReservoir Device for Intraocular Drug Delivery
US20160184134A1 (en)2001-06-122016-06-30Johns Hopkins University School Of MedicineReservoir Device for Intraocular Drug Delivery
US20110098686A1 (en)2001-06-122011-04-28Johns Hopkins UniversityReservoir Device for Intraocular Drug Delivery
US20180243131A1 (en)2001-06-122018-08-30The Johns Hopkins UniversityReservoir Device for Intraocular Drug Delivery
US7195778B2 (en)2001-07-102007-03-27Teva Pharmaceutical Industries Ltd.Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
US20040209359A1 (en)2001-07-192004-10-21Avner YayonPlasma protein matrices and methods for their preparation
EP1385452A1 (en)2001-07-232004-02-04Alcon, Inc.Ophthalmic drug delivery device
EP1409065A2 (en)2001-07-232004-04-21Alcon, Inc.Ophthalmic drug delivery device
US20040106906A1 (en)2001-07-232004-06-03Yoseph YaacobiOpthalmic drug delivery device
US20040092911A1 (en)2001-07-232004-05-13Yoseph YaacobiOphthalmic drug delivery device
US6986900B2 (en)2001-07-232006-01-17Alcon, Inc.Ophthalmic drug delivery device
US7094226B2 (en)2001-07-232006-08-22Alcon, Inc.Ophthalmic drug delivery device
US7195774B2 (en)2001-08-292007-03-27Carvalho Ricardo Azevedo PonteImplantable and sealable system for unidirectional delivery of therapeutic agents to tissues
US20050113806A1 (en)2001-08-292005-05-26De Carvalho Ricardo A.P.Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
US20040010228A1 (en)*2001-09-252004-01-15Becton, Dickinson And CompanyActivation of dual blunting needle assembly
WO2003028765A1 (en)2001-09-282003-04-10Santen Pharmaceutical Co., Ltd.Injections for eye tissue containing drug bound to polyethylene glycol
US20030118649A1 (en)2001-10-042003-06-26Jinming GaoDrug delivery devices and methods
US20100221309A1 (en)2001-10-122010-09-02Monosol Rx, LlcFilm compositions for delivery of actives
US20030119177A1 (en)2001-11-152003-06-26Lewis GruberSample chip
US20030120217A1 (en)2001-12-212003-06-26Abergel R. PatrickMethods and devices for sclerotherapy
US20060246112A1 (en)2002-01-182006-11-02Snyder Michael ESustained release ophthalmological device and method of making and using the same
US20060116626A1 (en)2002-03-072006-06-01Gregory SmedleyFluid infusion methods for glaucoma treatment
US7621907B2 (en)2002-03-112009-11-24Alcon, Inc.Implantable drug delivery system
US20100022945A1 (en)2002-03-112010-01-28Theron Robert RodstromImplantable drug delivery system
US20030176854A1 (en)2002-03-112003-09-18Alcon, Inc.Implantable drug delivery system
WO2003077972A2 (en)2002-03-112003-09-25Alcon, Inc.Implantable drug delivery system
WO2003082188A2 (en)2002-03-272003-10-09Frank KochinkeMethods and drug delivery systems for the treatment of orofacial diseases
US7074426B2 (en)2002-03-272006-07-11Frank KochinkeMethods and drug delivery systems for the treatment of orofacial diseases
US20030185872A1 (en)2002-03-272003-10-02Frank KochinkeMethods and drug delivery systems for the treatment of orofacial diseases
US20040029832A1 (en)2002-05-172004-02-12Zeldis Jerome B.Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
US20040260240A1 (en)2002-06-102004-12-23Dagmar BeyerleinSystems and methods for detecting tissue contact and needle penetration depth using static fluid pressure measurements
US20030233067A1 (en)2002-06-142003-12-18Mcintosh Kevin D.Multiple ratio fluid dispenser
US20030235603A1 (en)2002-06-192003-12-25Schwarz Marlene C.Multiphase polymeric drug release region
WO2004000267A1 (en)2002-06-192003-12-31Scimed Life Sytems, Inc.Method for modulation of drug release from multiphase implantable or insertable medical devices and a process for manufacturing such devices
US7939094B2 (en)2002-06-192011-05-10Boston Scientific Scimed, Inc.Multiphase polymeric drug release region
EP1521572B1 (en)2002-07-152009-03-04Alcon, Inc.Bioerodible film for ophthalmic drug delivery
US20100114017A1 (en)2002-07-232010-05-06Reverse Medical CorporationSystems and methods for removing obstructive matter from body lumens and treating vascular defects
US20040019325A1 (en)2002-07-292004-01-29Medrip Ltd.Syringe Pump
US20070219632A1 (en)2002-08-022007-09-20David CastillejosMethod and intra-sclera implant for treatment of glaucoma and presbyopia
US7468065B2 (en)2002-09-182008-12-23Allergan, Inc.Apparatus for delivery of ocular implants
US7090681B2 (en)2002-09-182006-08-15Allergan, Inc.Methods and apparatus for delivery of ocular implants
US20050154399A1 (en)2002-09-182005-07-14Allergan, Inc.Apparatus for delivery of ocular implants
US20050143363A1 (en)2002-09-292005-06-30Innorx, Inc.Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases
US20060200097A1 (en)2003-01-242006-09-07Doheny Retina InstituteReservoirs with subretinal cannula for subretinal drug delivery
US20040230183A1 (en)2003-02-182004-11-18Wisam BreegiDrug delivery device and syringe for filling the same
US20060258000A1 (en)2003-02-262006-11-16Allen Jared WUse of steady-state oxygen gradients to modulate animal cell functions
US20050074497A1 (en)2003-04-092005-04-07Schultz Clyde L.Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US20050255144A1 (en)2003-04-092005-11-17Directcontact LlcMethods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US7094222B1 (en)2003-04-282006-08-22The United States Of America As Represented By The Secretary Of NavySyringe device for simultaneous infusion and withdrawal
EP1671624A1 (en)2003-05-022006-06-21SurModics, Inc.Delivery device for a controlled drug release of an active agent into the posterior section of the eye
US20050281863A1 (en)2003-05-022005-12-22Anderson Aron BControlled release bioactive agent delivery device
US20050287188A1 (en)2003-05-022005-12-29Anderson Aron BControlled release bioactive agent delivery device
US20060013835A1 (en)2003-05-022006-01-19Anderson Aron BControlled release bioactive agent delivery device
US20050271703A1 (en)2003-05-022005-12-08Anderson Aron BControlled release bioactive agent delivery device
US20050271706A1 (en)2003-05-022005-12-08Anderson Aron BControlled release bioactive agent delivery device
US20050276837A1 (en)2003-05-022005-12-15Anderson Aron BControlled release bioactive agent delivery device
WO2005016401A2 (en)2003-06-132005-02-24Becton Dickinson And CompanyImproved intra-dermal delivery of biologically active agents
US20050163711A1 (en)2003-06-132005-07-28Becton, Dickinson And Company, Inc.Intra-dermal delivery of biologically active agents
WO2004112653A2 (en)2003-06-182004-12-29D-Crown Ltd.Devices and methods for delivering and forming single and multiple stenting structures in situ
US20040260380A1 (en)2003-06-182004-12-23D-Crown LtdDevices for delivering multiple stenting structures in situ
US20040260381A1 (en)2003-06-182004-12-23D-Crown LtdDevices and methods for forming stenting structures in situ
US20050112759A1 (en)2003-06-202005-05-26Milica RadisicApplication of electrical stimulation for functional tissue engineering in vitro and in vivo
US20060039952A1 (en)2003-07-102006-02-23Yoseph YaacobiOphthalmic drug delivery device
US20070235331A1 (en)2003-07-252007-10-11Dexcom, Inc.Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20070141111A1 (en)2003-08-202007-06-21Bioretec OyPorous medical device and method for its manufacture
WO2005025413A2 (en)2003-09-112005-03-24Theranos, Inc.Medical device for analyte monitoring and drug delivery
US7585517B2 (en)2003-09-182009-09-08Macusight, Inc.Transscleral delivery
US20090324686A1 (en)2003-09-182009-12-31Macusight, Inc.Transscleral delivery
US20090324687A1 (en)2003-09-182009-12-31Macusight, Inc.Transscleral delivery
US20050064010A1 (en)2003-09-182005-03-24Cooper Eugene R.Transscleral delivery
US20090324690A1 (en)2003-09-182009-12-31Macusight, Inc.Transscleral delivery
WO2005027906A1 (en)2003-09-182005-03-31Macusight, Inc.Transscleral delivery
US20090324688A1 (en)2003-09-182009-12-31Macusight, Inc.Transscleral delivery
US20090324689A1 (en)2003-09-182009-12-31Macusight, Inc.Transscleral delivery
US20050181018A1 (en)2003-09-192005-08-18Peyman Gholam A.Ocular drug delivery
US20070119450A1 (en)2003-09-242007-05-31Wharton David PMedication holder
WO2005028006A1 (en)2003-09-242005-03-31Medi-Stream Pty LtdMedication holder
US7686016B2 (en)2003-09-242010-03-30Medi-Stream Pty Ltd Acn 111 815 715Medication holder
US7615141B2 (en)2003-10-032009-11-10University Of WashingtonElectrochemical micromanufacturing system and method
US7211272B2 (en)2003-12-222007-05-01Bausch & Lomb IncorporatedDrug delivery device
US20050171491A1 (en)2004-01-292005-08-04Becton, Dickinson And CompanyIntravenous delivery system
US20050277802A1 (en)2004-02-122005-12-15Larsen Charles EMethod and apparatus for intraocular brachytherapy
US7276050B2 (en)2004-03-022007-10-02Alan FranklinTrans-scleral drug delivery method and apparatus
US20050256499A1 (en)2004-03-032005-11-17Pettis Ronald JMethods and devices for improving delivery of a substance to skin
US20090124997A1 (en)2004-03-032009-05-14Becton, Dickinson And CompanyMethods and devices for improving delivery of a substance to skin
WO2005091922A2 (en)2004-03-032005-10-06Becton, Dickinson And CompanyMethods and devices for improving delivery of a substance to skin
WO2005110473A2 (en)2004-04-092005-11-24Directcontact LlcMethods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US20050244469A1 (en)2004-04-302005-11-03Allergan, Inc.Extended therapeutic effect ocular implant treatments
US20080172014A1 (en)2004-04-302008-07-17Allergan, Inc.Extended therapeutic effect ocular implant treatments
US20070059336A1 (en)2004-04-302007-03-15Allergan, Inc.Anti-angiogenic sustained release intraocular implants and related methods
US20080233173A1 (en)2004-04-302008-09-25Allergan, Inc.Extended therapeutic effect ocular implant treatments
US20080233171A1 (en)2004-04-302008-09-25Allergan, Inc.Extended therapeutic effect ocular implant treatments
WO2005110436A2 (en)2004-04-302005-11-24Allergan, Inc.Macromolecule-containing sustained release intraocular implants and related methods
US20050281861A1 (en)2004-04-302005-12-22Allergan, Inc.Macromolecule-containing sustained release intraocular implants and related methods
US20060182783A1 (en)2004-04-302006-08-17Allergan, Inc.Sustained release intraocular drug delivery systems
US20080233172A1 (en)2004-04-302008-09-25Allergan, Inc.Extended therapeutic effect ocular implant treatments
US20050244467A1 (en)2004-04-302005-11-03Allergan, Inc.Extended release biodegradable ocular implants
US20080241221A1 (en)2004-04-302008-10-02Allergan, Inc.Extended therapeutic effect ocular implant treatments
US20080241223A1 (en)2004-04-302008-10-02Allergan, Inc.Extended release biodegradable ocular implants
US20080241220A1 (en)2004-04-302008-10-02Allergan, Inc.Extended therapeutic effect ocular implant treatments
US20080241222A1 (en)2004-04-302008-10-02Allergan, Inc.Extended therapeutic effect ocular implant treatments
US20050244472A1 (en)2004-04-302005-11-03Allergan, Inc.Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
WO2005110362A1 (en)2004-04-302005-11-24Allergan, Inc.Biodegradable ocular implants with long-term release characteristics
US20080241219A1 (en)2004-04-302008-10-02Allergan, Inc.Extended therapeutic effect ocular implant treatments
WO2005107705A2 (en)2004-04-302005-11-17Allergan, Inc.Extended therapeutic effect ocular implant treatments
US20110034448A1 (en)2004-04-302011-02-10Allergan, Inc.Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US20050256462A1 (en)2004-05-142005-11-17Underwood John RNozzle
WO2005117780A2 (en)2004-06-012005-12-15Becton, Dickinson And CompanyOcular implant and methods for making and using same
US20110159073A1 (en)2004-07-022011-06-30Eugene DejuanMethods and devices for the treatment of ocular conditions
US20060110428A1 (en)2004-07-022006-05-25Eugene DejuanMethods and devices for the treatment of ocular conditions
WO2006014484A2 (en)2004-07-022006-02-09Surmodics, Inc.Methods and devices for the treatment of ocular conditions
US7117870B2 (en)2004-07-262006-10-10Clarity CorporationLacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
WO2006015385A2 (en)2004-08-062006-02-09Sopherion Therapeutics, Inc.Anti-angiogenic peptides and methods of use thereof
US20090047335A1 (en)2004-08-062009-02-19Sopherion Therapeutics, Inc.Anti-angiogenic peptides and methods of use thereof
WO2006031358A2 (en)2004-08-132006-03-23Hyperbranch Medical Technology, Inc.Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
WO2006023530A2 (en)2004-08-162006-03-02Massachusetts Institute Of TechnologyCompositions and methods for enhancing structural and functional nervous system reorganization and recovery
US20060104969A1 (en)2004-08-162006-05-18Massachusetts Institute Of TechnologyCompositions and methods for enhancing structural and functional nervous system reorganization and recovery
WO2006031388A2 (en)2004-08-202006-03-23Hyperbranch Medical Technology, Inc.Dentritic polymers, crosslinked gels, and their uses in orthopedic applications
US20060052754A1 (en)2004-09-042006-03-09Fields Douglas WThumb trigger syringe pole
US20060057277A1 (en)2004-09-102006-03-16Chappa Ralph AMethods, devices, and coatings for controlled active agent release
US7709049B2 (en)2004-09-102010-05-04Surmodics, Inc.Methods, devices, and coatings for controlled active agent release
US20100083963A1 (en)2004-09-242010-04-08David Peter WhartonMedication holder
US7906136B2 (en)2004-10-012011-03-15Ramscor, Inc.Conveniently implantable sustained release drug compositions
US20110111006A1 (en)2004-10-012011-05-12Ramscor, Inc.Conveniently implantable sustained release drug compositions
US20080038316A1 (en)2004-10-012008-02-14Wong Vernon GConveniently implantable sustained release drug compositions
US20060073182A1 (en)2004-10-012006-04-06Wong Vernon GConveniently implantable sustained release drug compositions
US20080207502A1 (en)2004-10-142008-08-28Sopherion Therapeutics, Inc.Anti-Angiogenic Peptides and Methods of Use Thereof
US20060172941A1 (en)2004-10-142006-08-03Luca RastelliAnti-angiogenic peptides and methods of use thereof
WO2006044614A2 (en)2004-10-142006-04-27Sopherion Therapeutics, Inc.Anti-angiogenic peptides and methods of use thereof
US20100015157A1 (en)2004-10-202010-01-21Genentech, Inc.Antibody formulations
WO2006050221A2 (en)2004-10-292006-05-11The Regents Of The University Of CaliforniaPorous photonic crystals for drug delivery to the eye
US20060129215A1 (en)2004-12-092006-06-15Helmus Michael NMedical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery
WO2006068838A2 (en)2004-12-092006-06-29Boston Scientific Scimed, Inc.Medical devices having nanostructured regions
US20110014264A1 (en)2004-12-092011-01-20Boston Scientific Scimed, Inc.Medical Devices Having Nanostructured Regions For Controlled Tissue Biocompatibility And Drug Delivery
WO2006071554A2 (en)2004-12-232006-07-06Allergan, Inc.Improved apparatus for delivery of ocular implants
US20060154981A1 (en)2005-01-122006-07-13Alcon, Inc.Method of reducing intraocular pressure and treating glaucoma
US20080233053A1 (en)2005-02-072008-09-25Pharmalight Inc.Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
WO2006082588A2 (en)2005-02-072006-08-10Pharmalight Inc.Method and device for ophthalmic administration of active pharmaceutical ingredients
US20090074786A1 (en)2005-02-092009-03-19Macusight, Inc.Formulations for treating ocular diseases and conditions
US20060189608A1 (en)2005-02-232006-08-24Alcon, Inc.Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
US20060233858A1 (en)2005-03-082006-10-19Allergan, Inc.Systems and methods providing targeted intraocular drug delivery
US20060257450A1 (en)2005-03-212006-11-16Sreenivasu MudumbaDrug delivery systems for treatment of diseases or conditions
US20070077270A1 (en)2005-03-282007-04-05Clemson UniversityDelivery devices and methods for long-term, targeted delivery of therapeutic agents to the eye and ear
WO2006108054A2 (en)2005-04-052006-10-12The Ohio State UniversityDiffusion delivery system and methods of fabrication
US20060258994A1 (en)2005-05-122006-11-16Avery Robert LImplantable delivery device for administering pharmacological agents to an internal portion of a body
US20070088414A1 (en)2005-05-252007-04-19Campbell Robert LParticulate formulations for intradermal delivery of biologically active agents
WO2006127962A2 (en)2005-05-252006-11-30Becton, Dickinson And ComapnyParticulate formulations for intradermal delivery of biologically active agents
US20070021357A1 (en)2005-06-172007-01-25Dynamis Therapeutics, Inc.Treatment of inflammatory conditions
WO2006138609A2 (en)2005-06-172006-12-28Dynamis Therapeutics, Inc.Treatment of inflammatory conditions
US20110112188A1 (en)2005-06-172011-05-12Dynamis Therapeutics, Inc.Treatment of Inflammatory Conditions
US7893040B2 (en)2005-07-222011-02-22Oculis EhfCyclodextrin nanotechnology for ophthalmic drug delivery
WO2007012974A2 (en)2005-07-222007-02-01Oculis EhfCyclodextrin nanotechnology for ophthalmic drug delivery
US20070020336A1 (en)2005-07-222007-01-25Oculis EhfCyclodextrin nanotechnology for ophthalmic drug delivery
US20070026037A1 (en)2005-07-292007-02-01Kloke Timothy MDevices, articles, coatings, and methods for controlled active agent release or hemocompatibility
US20070078359A1 (en)2005-08-102007-04-05Luloh K PTool For Extracting Vitreous Samples From An Eye
WO2007035473A2 (en)2005-09-152007-03-29Roth Daniel BPharmaceutical delivery device and method for providing ocular treatment
US20130218081A1 (en)2005-09-152013-08-22Forsight Vision4, Inc.Pharmaceutical Delivery Device and Method for Providing Ocular Treatment
US20070212397A1 (en)2005-09-152007-09-13Roth Daniel BPharmaceutical delivery device and method for providing ocular treatment
WO2007035621A1 (en)2005-09-162007-03-29(Osi) Eyetech, Inc.Ophthalmic syringe
US20070072933A1 (en)2005-09-262007-03-29Peyman Gholam ADelivery of an ocular agent
US20070071756A1 (en)2005-09-262007-03-29Peyman Gholam ADelivery of an agent to ameliorate inflammation
WO2007038453A2 (en)2005-09-262007-04-05Advanced Ocular Systems LimitedUse of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
US20080167600A1 (en)2005-09-262008-07-10Peyman Gholam ADevice for delivery of an agent to the eye and other sites
US20080003219A1 (en)2005-09-262008-01-03Minu, L.L.C.Delivery of an ocular agent
US20070083155A1 (en)2005-09-272007-04-12Mile Creek Capital, LlcMulti-lumen injection apparatus
US20100216702A1 (en)2005-10-062010-08-26Szkudlinski Mariusz WVegf analogs and methods of use
WO2007044534A2 (en)2005-10-062007-04-19Trophogen, Inc.Vegf analogs and methods of use
US20090043253A1 (en)2005-10-112009-02-12Blake PodaimaSmart medical compliance method and system
US20070197491A1 (en)2005-10-142007-08-23Alcon, Inc.Method for treating primary and secondary forms of glaucoma
WO2007047744A2 (en)2005-10-142007-04-26Alcon, Inc.Method for treating primary and secondary forms of glaucoma
US20080293691A1 (en)2005-11-292008-11-27Smithkline Beecham CorporationTreatment Method
US20070128644A1 (en)2005-12-012007-06-07Canon Kabushiki KaishaFluid control method and fluid control apparatus
US20070134305A1 (en)2005-12-072007-06-14Ramot At Tel Aviv University Ltd.Drug-delivering composite structures
WO2007066339A1 (en)2005-12-072007-06-14Ramot At Tel Aviv University Ltd.Drug-delivering composite structures
US20070131611A1 (en)2005-12-132007-06-14General Electric CompanyMembrane-based article and associated method
US20070131610A1 (en)2005-12-132007-06-14General Electric CompanyMembrane-based apparatus and associated method
US20070191863A1 (en)2006-01-172007-08-16De Juan Eugene JrGlaucoma Treatment Device
US20070233037A1 (en)2006-01-172007-10-04Gifford Hanson S IiiDrug Delivery Treatment Device
WO2007084582A2 (en)2006-01-172007-07-26Forsight Labs, LlcDrug delivery treatment device
WO2007084765A2 (en)2006-01-192007-07-26Potentia Pharmaceuticals, Inc.Injectable combination therapy for eye disorders
US20080216736A1 (en)2006-01-192008-09-11Takeda San Diego, Inc.Microfluidic device with diffusion between adjacent lumens
US20090220572A1 (en)2006-01-192009-09-03Potentia Pharmaceuticals, Inc.Injectable Combination Therapy for Eye Disorders
US20090280470A1 (en)2006-02-242009-11-12Rosetta Inpharmatics LlcExtraction and diagnostic fluid devices, systems and methods of use
WO2007101204A1 (en)2006-02-272007-09-07Alcon Research, Ltd.Method of treating glaucoma
US7625927B2 (en)2006-02-272009-12-01Alcon Research, Ltd.Method of treating glaucoma
US20070203174A1 (en)2006-02-272007-08-30Alcon Manufacturing, Ltd.Method of treating glaucoma
US20070212388A1 (en)2006-03-082007-09-13Sahajanand Medical Technologies Pvt. Ltd.Compositions comprising porous articles and uses in implantable medical devices
US20100297046A1 (en)2006-03-312010-11-25Dynamis Therapeutics, Inc.Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors
WO2007115259A2 (en)2006-03-312007-10-11Qlt Plug Delivery, Inc.Nasolacrimal drainage system implants for drug therapy
US20070243230A1 (en)2006-03-312007-10-18Forsight Labs, LlcNasolacrimal Drainage System Implants for Drug Therapy
US20070269487A1 (en)2006-03-312007-11-22Forsight Labs, LlcDrug Delivery Methods, Structures, and Compositions for Nasolacrimal System
WO2007117394A2 (en)2006-03-312007-10-18Dynamis Therapeutics, Inc.Compositions and methods related to fructosamine-3-kinase inhibitors
US20090092654A1 (en)2006-03-312009-04-09Qlt Plug Delivery, Inc.Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System
US20110190723A1 (en)2006-04-122011-08-04Fangrow Thomas FPressure-regulating vials and containers
US20100168535A1 (en)2006-04-122010-07-01Mark Ries RobinsonMethods and apparatuses related to blood analyte measurement system
US20090326448A1 (en)2006-04-182009-12-31Pingan HuoSterile Drug-Mixing Syringe
US20070260201A1 (en)2006-05-022007-11-08Georgia Tech Research CorporationMethod for drug delivery to ocular tissue using microneedle
WO2007131050A2 (en)2006-05-022007-11-15Georgia Tech Research CorporationMethod for drug delivery to ocular tissue using microneedle
US20100256597A1 (en)2006-05-022010-10-07Emory UniversityMethods and Devices for Drug Delivery to Ocular Tissue Using Microneedle
US20070265599A1 (en)2006-05-122007-11-15David CastillejosOptic nerve head implant and medication delivery system
WO2007133762A1 (en)2006-05-152007-11-22Momentive Performance Materials Inc.Membrane-based article and associated method
WO2007133761A2 (en)2006-05-152007-11-22Momentive Performance Materials Inc.Membrane-based apparatus and associated method
US20080015545A1 (en)2006-05-172008-01-17Robert SanchezDual Thermal Coefficient Dispensing Chamber
US20080124372A1 (en)2006-06-062008-05-29Hossainy Syed F AMorphology profiles for control of agent release rates from polymer matrices
WO2008003043A2 (en)2006-06-282008-01-03Surmodics, Inc.Combination degradable and non-degradable matrices for active agent delivery
US20080020045A1 (en)2006-06-282008-01-24Chappa Ralph ACombination Degradable and Non-Degradable Matrices for Active Agent Delivery
WO2008005240A2 (en)2006-06-292008-01-10Jazz PharmaceuticalsRopinirole-containing pharmaceutical compositions in the form of a gel, uses thereof
US20080004329A1 (en)2006-06-292008-01-03Jazz PharmaceuticalsPharmaceutical compositions of ropinirole and methods of use thereof
US20100011888A1 (en)2006-07-192010-01-21Janusz PawliszynMethod and device to extract components contained in a fluid
WO2008011125A2 (en)2006-07-202008-01-24Neurosystec CorporationDevices, systems and methods for ophthalmic drug delivery
US20080152694A1 (en)2006-07-202008-06-26Neurosystec CorporationDevices, Systems and Methods for Ophthalmic Drug Delivery
US20080069854A1 (en)2006-08-022008-03-20Inframat CorporationMedical devices and methods of making and using
WO2008019265A2 (en)2006-08-042008-02-14Allergan, Inc.Ocular implant delivery assemblies
US20080057561A1 (en)2006-08-292008-03-06Canon Kabushiki KaishaCell culture treatment apparatus and cell culture treatment method
US20090087494A1 (en)2006-09-122009-04-02Board Of Regents Of The University Of NebraskaMethods and Compositions for Targeted Delivery of Therapeutic Agents
WO2008033924A2 (en)2006-09-122008-03-20Board Of Regents Of The University Of NebraskaMethods and compositions for targeted delivery of therapeutic agents
US20080066741A1 (en)2006-09-202008-03-20Lemahieu EdwardMethods and systems of delivering medication via inhalation
US20080066739A1 (en)2006-09-202008-03-20Lemahieu EdwardMethods and systems of delivering medication via inhalation
EP1911481A2 (en)2006-09-202008-04-16Next Safety, Inc.Methods and systems of delivering medication via inhalation
WO2008060359A2 (en)2006-09-292008-05-22Surmodics, Inc.Biodegradable ocular implants and methods for treating ocular conditions
US20080089923A1 (en)2006-09-292008-04-17Burkstrand Michael JBiodegradable ocular implants and methods for treating ocular conditions
WO2008040062A1 (en)2006-10-052008-04-10Medi-Stream Pty LtdMedication holder
WO2008045272A2 (en)2006-10-062008-04-17Dynamis Therapeutics, Inc.Compositions and methods for skin lightening
US20100030136A1 (en)2006-10-162010-02-04Bruno DacquayOphthalmic Injection Device Including Dosage Control Device
US20080146679A1 (en)2006-10-252008-06-19Revalesio CorporationMethods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
US20100021464A1 (en)2006-10-252010-01-28Revalesio CorporationMethods of wound care and treatment
US20100028442A1 (en)2006-10-252010-02-04Revalesio CorporationMethods of therapeutic treatment of eyes
US20110081384A1 (en)2006-10-252011-04-07Revalesio CorporationMethods of wound care and treatment
WO2008115290A2 (en)2006-10-252008-09-25Revalesio CorporationMethods of wound care and treatment
US20080139674A1 (en)2006-10-252008-06-12Revalesio CorporationMethods of wound care and treatment
WO2008052145A2 (en)2006-10-252008-05-02Revalesio CorporationMethods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
US20100297193A1 (en)2006-10-252010-11-25Revalesio CorporationMethods of therapeutic treatment of eyes
US20080108954A1 (en)2006-11-022008-05-08Jean-Marie MathiasFlow Controllers
US20080111282A1 (en)2006-11-102008-05-15Baojun XieProcess for Making Three Dimensional Objects From Dispersions of Polymer Colloidal Particles
WO2008061043A2 (en)2006-11-102008-05-22Glaukos CorporationUveoscleral shunt and methods for implanting same
US20080228127A1 (en)2006-11-102008-09-18Glaukos CorporationUveoscleral shunt and methods for implanting same
US20100286791A1 (en)2006-11-212010-11-11Goldsmith David SIntegrated system for the ballistic and nonballistic infixion and retrieval of implants
US20110009571A1 (en)2006-12-052011-01-13David TaftSystems and methods for delivery of materials
US20090263346A1 (en)2006-12-052009-10-22David TaftSystems and methods for delivery of drugs
US20080154241A1 (en)2006-12-072008-06-26Burkstrand Michael JLatent stabilization of bioactive agents releasable from implantable medical articles
US20080147021A1 (en)2006-12-152008-06-19Jani Dharmendra MDrug delivery devices
US20090326489A1 (en)2006-12-162009-12-31Arnd KensyApplicator for a water jet separating apparatus
WO2008076544A2 (en)2006-12-182008-06-26Alcon Research, Ltd.Devices and methods for ophthalmic drug delivery
US20080145406A1 (en)2006-12-182008-06-19Alcon Manufacturing Ltd.Devices and methods for ophthalmic drug delivery
US20100266664A1 (en)2006-12-182010-10-21Alcon Research, Ltd.Devices And Methods For Ophthalmic Drug Delivery
US20100114309A1 (en)2006-12-262010-05-06De Juan Jr EugeneDrug delivery implants for inhibition of optical defects
US20100010452A1 (en)2007-01-092010-01-14Fovea PharmaceuticalsApparatus for intra-ocular injection
US20080213611A1 (en)2007-01-192008-09-04Cinvention AgPorous, non-degradable implant made by powder molding
WO2008094989A2 (en)2007-01-312008-08-07Alcon Research, Ltd.Punctal plugs and methods of delivering therapeutic agents
US20080181930A1 (en)2007-01-312008-07-31Alcon Research, Ltd.Punctal Plugs and Methods of Delivering Therapeutic Agents
US20080195218A1 (en)2007-02-142008-08-14Benoist Girard SasProsthetic implant for use without bone cement
WO2008116165A2 (en)2007-03-212008-09-25Next Safety, Inc.Methods and systems of delivering medication via inhalation
US20090012485A1 (en)2007-03-232009-01-08Michaels Thomas LFluid collection and disposal system having interchangeable collection and other features and methods relating thereto
US20080249501A1 (en)2007-04-092008-10-09Medtronic Vascular, Inc.Methods for Simultaneous Injection and Aspiration of Fluids During a Medical Procedure
US20080286338A1 (en)2007-05-152008-11-20Boston Foundation For SightDrug delivery system with scleral lens
WO2008144340A2 (en)2007-05-152008-11-27Boston Foundation For SightDrug delivery system with scleral lens
US20080292679A1 (en)2007-05-242008-11-27Allergan, Inc.Biodegradable drug delivery system
US20100297120A1 (en)2007-05-292010-11-25Angiochem Inc.Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2008144919A1 (en)2007-05-292008-12-04Angiochem, Inc.Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2009012075A1 (en)2007-07-162009-01-22Alcon, Inc.Use of iop-lowering agents for treating primary and secondary forms of glaucoma
US20100211041A1 (en)2007-07-302010-08-19Masayoshi OmoriApparatus for separating and storing blood components
US20090036827A1 (en)2007-07-312009-02-05Karl CazziniJuxtascleral Drug Delivery and Ocular Implant System
US7909800B2 (en)2007-07-312011-03-22Alcon Research, Ltd.Juxtascleral drug delivery and ocular implant system
WO2009023615A1 (en)2007-08-102009-02-19Trustees Of Tufts CollegeTubular silk compositions and methods of use thereof
US20090061071A1 (en)2007-08-312009-03-05Boston Scientific Scimed, Inc.Porous medical articles for therapeutic agent delivery
CN102112076A (en)2007-09-072011-06-29Qlt栓塞输送公司Lacrimal implants and related methods
US20090104243A1 (en)2007-09-072009-04-23Qlt Plug Delivery, Inc. - QpdiDrug cores for sustained release of therapeutic agents
US20090099626A1 (en)2007-09-072009-04-16Qlt Plug Delivery, Inc. - QpdiLacrimal implant detection
US20090105749A1 (en)2007-09-072009-04-23Qlt Plug Delivery, Inc. - QpdiInsertion and extraction tools for lacrimal implants
US20090082631A1 (en)2007-09-242009-03-26Cronin Michael DElliptical retractor
US20090081271A1 (en)2007-09-242009-03-26John ClarkeMedical devices having a filter insert for controlled diffusion
US20090081272A1 (en)2007-09-242009-03-26John ClarkeMedical devices having a metal particulate composition for controlled diffusion
US20090214601A1 (en)2007-09-282009-08-27Chappa Ralph APorous Drug Delivery Devices and Related Methods
WO2009046164A1 (en)2007-10-052009-04-09Tyco Healthcare Group LpSeal anchor for use in surgical procedures
US20090093752A1 (en)2007-10-052009-04-09Tyco Healthcare Group LpSeal anchor for use in surgical procedures
WO2009055620A1 (en)2007-10-252009-04-30Revalesio CorporationBacteriostatic or bacteriocidal compositions and methods
WO2009055729A1 (en)2007-10-252009-04-30Revalesio CorporationCompositions and methods for treating inflammation
US20100028443A1 (en)2007-10-252010-02-04Revalesio CorporationCompositions and methods for treating inflammation
US20090274730A1 (en)2007-10-252009-11-05Revalesio CorporationCompositions and methods for treating inflammation
US20090274771A1 (en)2007-10-252009-11-05Revalesio CorporationCompositions and methods for treating asthma and other lung disorders
US20100009008A1 (en)2007-10-252010-01-14Revalesio CorporationBacteriostatic or bacteriocidal compositions and methods
US20100008997A1 (en)2007-10-252010-01-14Revalesio CorporationCompositions and methods for treating asthma and other lung disorders
US20090247458A1 (en)2007-10-252009-10-01Revalesio CorporationCompositions and methods for treating cystic fibrosis
US20100303918A1 (en)2007-10-252010-12-02Revalesio CorporationCompositions and methods for treating asthma and other lung disorders
US20090263495A1 (en)2007-10-252009-10-22Revalesio CorporationBacteriostatic or bacteriocidal compositions and methods
US20100004189A1 (en)2007-10-252010-01-07Revalesio CorporationCompositions and methods for treating cystic fibrosis
US20100316723A1 (en)2007-10-252010-12-16Revalesio CorporationCompositions and methods for treating inflammation
WO2009055671A1 (en)2007-10-252009-04-30Revalesio CorporationCompositions and methods for treating cystic fibrosis
WO2009055824A1 (en)2007-10-252009-04-30Revalesio CorporationCompositions and methods for treating asthma and lung disorders
US20100310665A1 (en)2007-10-252010-12-09Revalesio CorporationBacteriostatic or bacteriocidal compositions and methods
US20100303917A1 (en)2007-10-252010-12-02Revalesio CorporationCompositions and methods for treating cystic fibrosis
WO2009061607A2 (en)2007-11-052009-05-14Bausch & Lomb IncorporatedWater-immiscible materials as vehicles for drug delivery
US20100286121A1 (en)2007-11-052010-11-11Rohrs Brian RWater-Immiscible Materials as Vehicles for Drug Delivery
US20090124986A1 (en)2007-11-082009-05-14Terumo Kabushiki KaishaSprayer
WO2009073192A2 (en)2007-12-042009-06-11Landec CorporationSystems and methods for delivery of materials
WO2009086112A2 (en)2007-12-202009-07-09University Of Southern CaliforniaApparatus and methods for delivering therapeutic agents
US20090240215A1 (en)2007-12-202009-09-24Mark HumayunApparatus and methods for delivering therapeutic agents
US20090234449A1 (en)2007-12-272009-09-17De Juan Jr EugeneIntraocular, accommodating lens and methods of use
US20090192493A1 (en)2008-01-032009-07-30University Of Southern CaliforniaImplantable drug-delivery devices, and apparatus and methods for refilling the devices
WO2009089409A2 (en)2008-01-102009-07-16Bausch & Lomb IncorporatedIntravitreal injection system having coaxial cannulae and use thereof
US20100330146A1 (en)2008-01-222010-12-30University Of Florida Research Foundation Inc.Contact lenses for extended release of bioactive agents containing diffusion attenuators
WO2009094466A2 (en)2008-01-222009-07-30University Of Florida Research Foundation, Inc.Contact lenses for extended release of bioactive agents containing diffusion attenuators
US20090196903A1 (en)2008-01-292009-08-06Kliman Gilbert HDrug delivery devices, kits and methods therefor
USD604836S1 (en)*2008-03-072009-11-24Becton, Dickinson And CompanySafety blood collection assembly
USD651308S1 (en)*2008-03-072011-12-27Becton, Dickinson And CompanySafety blood collection assembly
US20090224064A1 (en)2008-03-102009-09-10Vapore, Inc.Low Energy Vaporization of Liquids: Apparatus and Methods
US20110104155A1 (en)2008-03-112011-05-05Raouf RekikDrug delivery to the anterior and posterior segments of the eye using eye drops
WO2009112878A1 (en)2008-03-112009-09-17Raouf RekikDrug delivery to the anterior and posterior segments of the eye using eye drops.
US20090240208A1 (en)2008-03-192009-09-24Warsaw Orthopedic, Inc.Microparticle delivery syringe and needle for placing particle suspensions and removing vehicle fluid
WO2009117112A2 (en)2008-03-212009-09-24Novartis AgPowder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents
WO2009124096A1 (en)2008-03-312009-10-08Altea Therapeutics CorporationPermeant delivery system and methods for use thereof
US20110108025A1 (en)2008-04-042011-05-12Nektar TherapeuticsAerosolization device
WO2010008424A2 (en)2008-04-042010-01-21Novartis AgAerosolization device
US20090259212A1 (en)2008-04-102009-10-15Sabbah Hani NApparatus and method for controlled depth of injection into myocardial tissue
US20090258069A1 (en)2008-04-152009-10-15John BurnierDelivery of LFA-1 antagonists to the gastrointestinal system
WO2009128932A1 (en)2008-04-152009-10-22Sarcode CorporationDelivery of lfa-1 antagonists to the gastrointestinal system
US20100034870A1 (en)2008-04-302010-02-11QLT. Plug Delivery, Inc.Composite lacrimal insert and related methods
WO2009134929A2 (en)2008-05-012009-11-05Revalesio CorporationCompositions and methods for treating digestive disorders
US20100003333A1 (en)2008-05-012010-01-07Revalesio CorporationCompositions and methods for treating digestive disorders
WO2009137777A2 (en)2008-05-082009-11-12Replenish Pumps, LlcImplantable drug-delivery devices, and apparatus and methods for filling the devices
WO2009137780A2 (en)2008-05-082009-11-12Replenish Pumps, LlcImplantable pumps and cannulas therefor
US20090306595A1 (en)2008-05-082009-12-10Jason ShihImplantable drug-delivery devices, and apparatus and methods for filling the devices
US20090306025A1 (en)2008-05-302009-12-10Fairfield Clinical Trials, LlcMethod and composition for skin inflammation and discoloration
US20090318545A1 (en)2008-06-092009-12-24Cornell Reasearch Foundation, Inc.Mast cell inhibition in diseases of the retina and vitreous
US20100197512A1 (en)2008-07-112010-08-05IntellicytMulti-Sample Particle Analyzer and Method for High Throughput Screening
US20100015158A1 (en)2008-07-182010-01-21Allergan, Inc.Method for treating atrophic age related macular degeneration
US20100016786A1 (en)2008-07-212010-01-21Arstasis, Inc.Devices, methods, and kits for forming tracts in tissue
US20100022943A1 (en)2008-07-252010-01-28Medtronic Vascular, Inc.Hydrodynamic Thrombectomy Catheter
US20100023033A1 (en)2008-07-252010-01-28Medtronic Vescular, Inc.Hydrodynamic Thrombectomy Catheter
US7699820B1 (en)2008-08-122010-04-20French Ronald JDevice for irrigating the ear canal
US20110206646A1 (en)2008-08-192011-08-25Zeni AlfonsoMethods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
WO2010021993A1 (en)2008-08-192010-02-25Cytori Therapeutics, Inc.Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
US20100100054A1 (en)2008-10-212010-04-22Michel CormierIntravitreal injection device and system
US7678078B1 (en)2008-10-212010-03-16KMG Pharma LLCIntravitreal injection device, system and method
WO2010047753A1 (en)2008-10-212010-04-29KMG Pharma LLCIntravitreal injection device, system and method
WO2010062628A1 (en)2008-10-272010-06-03Revalesio CorporationCompositions and methods for treating asthma and other lung disorders
USD609804S1 (en)*2008-11-202010-02-09Nipro CorporationBlood sampling needle
US20100189765A1 (en)2008-11-262010-07-29Erickson Signe RImplantable ocular drug delivery device and methods
WO2010066714A1 (en)2008-12-092010-06-17Pari Pharma GmbhAerosol therapy device
US20100158980A1 (en)2008-12-182010-06-24Casey KopczynskiDrug delivery devices for delivery of therapeutic agents
WO2010075565A2 (en)2008-12-232010-07-01Reverse Medical CorporationSystems and methods for removing obstructive matter from body lumens and treating vascular defects
WO2010078063A1 (en)2009-01-022010-07-08Alcon Research, Ltd.In-situ refillable ophthalmic implant
US20100174272A1 (en)2009-01-022010-07-08Weiner Alan LIn-situ refillable ophthalmic implant
US20100185205A1 (en)2009-01-162010-07-22Allergan, Inc.Interocular injector
US20100191176A1 (en)2009-01-232010-07-29Iscience Interventional CorporationSubretinal access device
US20100255061A1 (en)2009-01-292010-10-07Forsight Labs, LlcPosterior Segment Drug Delivery
US20180292403A1 (en)2009-01-292018-10-11Forsight Vision4, Inc.Posterior Segment Drug Delivery
US20130204209A1 (en)2009-01-292013-08-08Eugene de Juan, Jr.Posterior Segment Drug Delivery
US20140073714A1 (en)2009-01-292014-03-13Forsight Vision4, Inc.Posterior Segment Drug Delivery
US20140121609A1 (en)2009-01-292014-05-01Forsight Vision4, Inc.Implantable therapeutic device
US8399006B2 (en)2009-01-292013-03-19Forsight Vision4, Inc.Posterior segment drug delivery
US20150297402A1 (en)2009-01-292015-10-22Forsight Vision4, Inc.Implantable Therapeutic Device
US8277830B2 (en)2009-01-292012-10-02Forsight Vision4, Inc.Posterior segment drug delivery
US20160101046A1 (en)2009-01-292016-04-14Forsight Vision4, Inc.Posterior segment drug delivery
WO2010088548A1 (en)2009-01-292010-08-05Forsight Labs, LlcPosterior segment drug delivery
US20130245573A1 (en)2009-01-292013-09-19Forsight Vision4, Inc.Posterior Segment Drug Delivery
US20120029445A1 (en)2009-01-292012-02-02Forsight Vision4, Inc.Posterior segment drug delivery
US20120029470A1 (en)2009-01-292012-02-02Forsight Vision4, Inc.Posterior segment drug delivery
US20120029469A1 (en)*2009-02-062012-02-02Becton, Dickerson and CompanyLubricated pen needle
US20120022459A1 (en)*2009-02-062012-01-26Horvath JoshuaPen needle to facilitate manipulation by users having physical or visual impairment
WO2010093945A2 (en)2009-02-132010-08-19Glaukos CorporationUveoscleral drug delivery implant and methods for implanting the same
WO2010095940A2 (en)2009-02-202010-08-26To-Bbb Holding B.V.Glutathione-based drug delivery system
US20100227904A1 (en)2009-03-032010-09-09Alcon Research, Ltd.Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
US20100223979A1 (en)2009-03-042010-09-09University Of South CarolinaSystems and Methods for Measurement of Gas Permeation Through Polymer Films
US20100310664A1 (en)2009-04-272010-12-09Revalesio CorporationCompositions and methods for treating insulin resistance and diabetes mellitus
WO2010126908A1 (en)2009-04-272010-11-04Revalesio CorporationCompositions and methods for treating insulin resistance and diabetes mellitus
WO2010125416A1 (en)2009-04-272010-11-04Raouf RekikDrug delivery to the anterior and posterior segments of the eye
US20110125178A1 (en)2009-05-152011-05-26Michael DrewsDevices, methods and kits for forming tracts in tissue
WO2010135369A1 (en)2009-05-182010-11-25Dose Medical CorporationDrug eluting ocular implant
WO2010141729A1 (en)2009-06-032010-12-09Forsight Labs, LlcAnterior segment drug delivery
WO2010147661A1 (en)2009-06-162010-12-23KMG Pharma LLCIntravitreal injection device and system
WO2011008897A2 (en)2009-07-142011-01-20Board Of Regents, The University Of Texas SystemMethods for making controlled delivery devices having zero order kinetics
WO2011008896A2 (en)2009-07-142011-01-20Board Of Regents, The University Of Texas SystemTherapeutic methods using controlled delivery devices having zero order kinetics
US20110033933A1 (en)2009-07-152011-02-10Morteza GharibMethod applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves
US20110117083A1 (en)2009-08-142011-05-19Genentech, Inc.Biological markers for monitoring patient response to vegf antagonists
WO2011028850A1 (en)2009-09-012011-03-10Northwestern UniversityDelivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers
US20120179115A1 (en)*2009-09-182012-07-12Horvath JoshuaSeparable hub post of pen needle
US20110071492A1 (en)*2009-09-182011-03-24Becton, Dickinson And CompanyHub assembly having a hidden needle for a drug delivery pen
WO2011034627A2 (en)2009-09-212011-03-24Harvard Bioscience, Inc.Methods and apparatus for introducing cells at a tissue site
WO2011079232A1 (en)2009-12-232011-06-30Psivida Us, Inc.Sustained release delivery devices
US20140358125A1 (en)2010-01-292014-12-04Forsight Vision4, Inc.Small molecule delivery with implantable therapeutic device
US20120095439A1 (en)2010-01-292012-04-19De Juan Jr EugeneImplantable therapeutic device
US8623395B2 (en)2010-01-292014-01-07Forsight Vision4, Inc.Implantable therapeutic device
US20120184905A1 (en)2010-02-222012-07-19Microsert Ltd.Slow release liquid drug delivery device
US20110281901A1 (en)2010-05-052011-11-17Glaxo Wellcome Manufacturing Pte Ltd.Pharmaceutical compositions and methods of making same
USD667951S1 (en)*2010-07-282012-09-25Owen Mumford LimitedTorque limiting needle cap
US20130245544A1 (en)2010-08-052013-09-19Forsight Vision4, Inc.Injector Apparatus and Method for Drug Delivery
US8905963B2 (en)2010-08-052014-12-09Forsight Vision4, Inc.Injector apparatus and method for drug delivery
US20130324942A1 (en)2010-08-052013-12-05Eugene de Juan, Jr.Implantable therapeutic device
US20130324918A1 (en)2010-08-052013-12-05Eugene de Juan, Jr.Injector apparatus and method for drug delivery
US20180161202A1 (en)2010-08-052018-06-14Forsight Vision4, Inc.Injector Apparatus and Method for Drug Delivery
WO2012019136A2 (en)2010-08-052012-02-09Forsight Vision 4, Inc.Injector apparatus and method for drug delivery
WO2012019047A2 (en)2010-08-052012-02-09Forsight Vision4, Inc.Subconjunctival implant for posterior segment drug delivery
US20130274692A1 (en)2010-08-052013-10-17Yair AlsterSubconjuctival implant for posterior segment drug delivery
US20190336335A1 (en)2010-08-052019-11-07Forsight Vision4, Inc.Injector apparatus and method for drug delivery
US20130274691A1 (en)2010-08-052013-10-17Forsight Vision4, Inc.Combined drug delivery methods and apparatus
US20150250647A1 (en)2010-08-052015-09-10Forsight Vision4, Inc.Injector Apparatus and Method for Drug Delivery
US9033911B2 (en)2010-08-052015-05-19Forsight Vision4, Inc.Injector apparatus and method for drug delivery
US20160258855A1 (en)2010-11-112016-09-08Forsight Vision4, Inc.Methods and Apparatus to Determine Diffusion Properties of Porous Structures for Drug Delivery
WO2012065006A2 (en)2010-11-112012-05-18Forsight Vision4, Inc.Methods and apparatus to determine porous structures for drug delivery
US20140033800A1 (en)2010-11-112014-02-06Forsight Vision4, Inc.Methods and apparatus to determine diffusion properties of porous structures for drug delivery
US20170258634A1 (en)2010-11-192017-09-14Forsight Vision4, Inc.Therapeutic Agent Formulations For Implanted Devices
US20140031769A1 (en)2010-11-192014-01-30Forsight Vision4, Inc.Therapeutic agent formulations for implanted devices
US20120296423A1 (en)2011-05-162012-11-22Sean CaffeyFilling and implanting accommodative intraocular lenses
WO2013003620A2 (en)2011-06-282013-01-03Forsight Vision4, Inc.Diagnostic methods and apparatus
US20140221941A1 (en)2011-06-282014-08-07Forsight Vision4, Inc.Diagnostic methods and apparatus
US20200030142A1 (en)2011-06-282020-01-30Forsight Vision4, Inc.Diagnostic methods and apparatus
WO2013022801A1 (en)2011-08-052013-02-14Forsight Vision4, Inc.Small molecule delivery with implantable therapeutic device
US20180243130A1 (en)2011-09-162018-08-30Forsight Vision4, Inc.Fluid exchange apparatus and methods
US20130165860A1 (en)2011-09-162013-06-27Darren DoudFluid exchange apparatus and methods
WO2013040247A2 (en)2011-09-162013-03-21Forsight Vision4, Inc.Fluid exchange apparatus and methods
US20130338564A1 (en)2011-12-122013-12-19Alcon Research, Ltd.Glaucoma drainage devices including vario-stable valves and associated systems and methods
US20180289542A1 (en)2012-02-032018-10-11Forsight Vision4, Inc.Insertion and removal methods and apparatus for therapeutic devices
US20150080846A1 (en)2012-02-032015-03-19Forsight Vision4, Inc.Insertion and removal methods and apparatus for therapeutic devices
WO2013151904A1 (en)2012-04-022013-10-10Ocuject, LlcIntraocular delivery devices and methods therefor
USD690008S1 (en)*2012-11-062013-09-17Shanghai Jinta Medical Apparatus Co., Ltd.Safety medical lancet
USD823457S1 (en)*2012-12-142018-07-17Retractable Technologies, Inc.Blood collection tube holder with offset needle retraction chamber and frontal attachment
US20140276482A1 (en)2013-03-142014-09-18Forsight Vision4, Inc.Systems for Sustained Intraocular Delivery of Low Solubility Compounds from a Port Delivery System Implant
US20170165110A1 (en)2013-03-282017-06-15Forsight Vision4, Inc.Ophthalmic implant for delivering therapeutic substances
US20140296800A1 (en)2013-03-282014-10-02Forsight Vision4, Inc.Ophthalmic Implant for Delivering Therapeutic Substances
US20200107955A1 (en)2013-03-282020-04-09Forsight Vision4, Inc.Ophthalmic implant for delivering therapeutic substances
CN105979985A (en)2013-10-072016-09-28奥库杰克特有限责任公司Intraocular delivery devices and methods therefor
US20160302965A1 (en)2013-12-062016-10-20Forsight Vision4, Inc.Implantable therapeutic devices
CN106413642A (en)2014-04-232017-02-15塞罗斯医学有限责任公司Vacuum-assisted drug delivery device
US20170165108A1 (en)2014-07-152017-06-15Forsight Vision4, Inc.Ocular implant delivery device and method
US20190350754A1 (en)2014-07-152019-11-21Forsight Vision4, Inc.Ocular implant delivery device and method
US20180147204A1 (en)2014-08-082018-05-31Forsight Vision4, Inc.Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
US20190365757A1 (en)2014-08-082019-12-05Forsight Vision4, Inc.Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
US20160038488A1 (en)2014-08-082016-02-11Forsight Vision4, Inc.Stable and Soluble Formulations of Receptor Tyrosine Kinase Inhibitors, and Methods of Preparation Thereof
US20200060874A1 (en)2014-11-102020-02-27Forsight Vision4, Inc.Expandable drug delivery devices and methods of use
US20220087863A1 (en)2014-11-102022-03-24Forsight Vision4, Inc.Expandable drug delivery devices and methods of use
US20160128867A1 (en)2014-11-102016-05-12Forsight Vision4, Inc.Expandable Drug Delivery Devices and Methods of Use
CN204600878U (en)2015-03-172015-09-02同济大学附属第十人民医院A kind of injection needle device
US20170087016A1 (en)2015-09-302017-03-30Camras Vision, Inc.Method and apparatus for reducing intraocular pressure
WO2017087902A1 (en)2015-11-202017-05-26Forsight Vision4, Inc.Porous structures for extended release drug delivery devices
US20210205130A1 (en)2015-11-202021-07-08Forsight Vision4, Inc.Porous structures for extended release drug delivery devices
US20190117454A1 (en)2016-04-052019-04-25Forsight Vision4, Inc.Implantable Ocular Drug Delivery Devices
USD823458S1 (en)*2016-07-052018-07-17Retractable Technologies, Inc.Blood collection tube holder
USD853563S1 (en)2017-08-232019-07-09Jjgc Indústria E Comércio De Materiais Dentários S.A.Star shaped driver
USD901683S1 (en)2017-10-272020-11-10Glaukos CorporationImplant delivery apparatus
US20200337897A1 (en)2017-11-212020-10-29Forsight Vision4, Inc.Fluid exchange apparatus for expandable port delivery system and methods of use
TWM577313U (en)2019-01-142019-05-01大學光學科技股份有限公司Cataract crystal nucleus breaking device
USD911518S1 (en)*2019-07-312021-02-23Shali Medical (Suzhou) Inc.Needle shield
US20230181829A1 (en)*2020-08-142023-06-15pHi-Tech Animal Health Technologies Ltd.Injection apparatus and method for aquatic species
JP1739057S (en)*2022-01-242023-03-15 fluid changer

Non-Patent Citations (65)

* Cited by examiner, † Cited by third party
Title
"Juvederm", FDA, 2006, XP002670727, Retrieved from the Internet: URL:http://www.accessdata.fda.gov/cdrh_docs/pdf5/P050047b.pdf [retrieved on Mar. 1, 2012] p. 1, last paragraph.
"MAbPac SCX-10 Column for Monoclonal Antibody Variant Analysis." Dionex. Aug. 2010. [http://www.dionex.com/en-us/webdocs/87008-DS-MAbPac-SCX-10-Column-20Aug2010-LPN2567-03.pdf]. Web. Retrieved May 2012. 4 pages.
Andrews, "Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa," Am J Physiol. Apr. 1994;266(4 Pt 1):G657-664.
Arvo, Agenda for the Summer Eye Research Conference, (Jul. 2009). 7 pages.
Avery et al., "Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy," Ophthalmology. Oct. 2006, 113(10):1695-1705.e6.
Bakri et al., "The effect of intravitreal triamcinolone acetonide on intraocular pressure," Ophthalmic Surgery, Lasers and Imaging, Sep./Oct. 2003; 34(5): 386-390.
Bantseev, V. (2021)."Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration." Toxicologic Pathology, 49(3), 663-672. https://doi.org/10.1177/0192623320968079.
Bird et al., Transport Phenomena, John Wiley & Sons, Inc., New York, 1960, pp. 196-201.
Block et al., "Solubility and dissolution of triamcinolone acetonide," Journal of Pharmaceutical Sciences, Apr. 1973; 62(4):617-621.
Breslin, C.W., et al., "Chapter 7. Slow Release Artificial Tears", Symposium on Ocular Therapy pp. 77-83, 1977.
Carbonaro, et al. "Nano-pore silicon membrane characterization by diffusion and electrical resistance." Journal of Membrane Science. 241 (2004):249-255.
Castro et al., "Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization," Exp Eye Res. Aug. 2004;79(2):275-285.
Chirila et al., "The Vitreous Humor" in Handbook of Biomaterial Properties, eds. Black & Hastings. Chapman & Hall, London, 1998; pp. 125-131.
Cousins et al., "Program # 1251—Targeting Complement Factor 5 in Combination with Vascular Endothelial Growth Factor (VEGF) Inhibition for Neovascular Age Related Macular Degeneration (AMD): Results of a Phase 1 Study," [Presentation Abstract], AMD Clinical Trials Session # 220, May 3, 2010. 2 pages.
Deissler et al., "VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells," Br J Ophthalmol 2008;92:839-843.
Del Amo, et al., Current & future ophthalmic drug delivery systems . . . , Drug Discovery Today, vol. 13, Nos. 3/4, Feb. 2008:135-143.
Donoso et al., "The role of inflammation in the pathogenesis of age-related macular degeneration," Surv Ophthalmol. Mar.-Apr. 2006;51(2):137-52.
Duvvuri et al., Drug Delivery to the Retina: Challenges and Opportunities, Expert Opinion on Biological Therapy, 2003, vol. 3(1):45-56.
European Medicine Agency, Scientific Discussion; retrieved from the Internet; <http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-Scientific_Discussion/human/000715/WC500043550.pdf>, EMEA 2007, 54 pages total. 2007.
Funatsu et al. "Association of vitreous inflammatory factors with diabetic macular edema," Ophthalmology 2009;116:73-79.
Gaudana et al., Recent Perspectives in Ocular Drug Delivery, Pharmaceutical Research, 2008. 20 pages.
Gaudreault et al., "Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration," Investigative Ophthalmology and Visual Science. 2005;46:726-733. Retrieved from the Internet: <<http://www.iovs.org/cgi/reprint/46/2/726>>.
Genentech. (2021). Susvimo: Highlights of Prescribing Information. South San Francisco, CA: Genentech Inc. 31 pages.
Genentech. (2021). Susvimo: Medication Guide. South San Francisco, CA: Genentech Inc. 3 pages.
Gillies et al., "Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial," Ophthalmology. Sep. 2006;113(9):1533-1538.
Haller, An Overview of Sustained-release Drug Implants, Retinal Physician, Jan. 2008. 4 pages.
Hastedt & Wright, "Diffusion in porous materials above the percolation threshold," Pharm. Res. Sep. 1990; 7(9):893-901 (1990).
Heier et al., "Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema," Ophthalmology. Nov. 2000;107(11):2034-2038, discussion 2039.
Inox Opthalmic Needles, Inox, [Post date: Jun. 16, 2021], [Site seen Nov. 15, 2023], Seen at URL: https://www.t-injecta.sk/en/needles/inox-ophthalmic-needles (Year: 2021).*
Janoria, KG et al. (2007). "Novel Approaches to Retinal Drug Delivery," Expert Opinion Drug Delivery, 4(4): 371-388.
Jena et al., "A Novel Technique for Surface Area and Particle Size Determination of Components of Fuel Cells and Batteries," Porous Materials, Inc., Dec. 2006, 3 pages total. Downloaded from the Internet: <<http://www.pmiapp.com/publications/docs/A_Novel_technique_for_surface_area.pdf>>.
Jornitz et al. "Filter Integrity Testing in Liquid Applications, Revisited; Part 1." Pharmaceutical Technology. Oct. 2001. pp. 34-50.
Kang et al., "Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity," Biol Pharm Bull. Jun. 2001;24(6):701-703.
Katz, I.M., et al., "A Soluble Sustained-Release Ophthalmic Delivery Unit", 8:5 (May 1977) pp. 728-734.
Lamberts, D.W., M.D., et al., "A Clinical Study of Slow-Releasing Artificial Tears", Ophthalmology 85 (1978) pp. 794-800.
Lee, D.A., et al., "Glaucoma Filtration Surgery in Rabbits Using Bioerodible Polymers and 5-Fluorouracil", Ophthalmology 94:12 (1987) pp. 1523-1530.
Lee, D.A., et al., "The Use of Bioerodible Polymers and 5-Fluorouracil in Glaucoma Filtration Surgery", Investigative Ophthalmology & Visual Science 29-11 (1988) pp. 1692-1697.
Li, P-Y et al., (2008). "An electrochemical introculardrug delivery device," Science Direct, Sensors and Actuators, pp. 41-48. www.sciencedirect.com.
Lopez-Armada et al., "Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis," Ann Rheum Dis Nov. 2002;61(11):1027-1030.
Luncentis, INN-Ranibizumab, (2010). "Scientific Discussion," European Medicines Agency, retrieved from the Internet:<http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-Assessment_Report_-_Variation/human/000715/WC500101009.pdf>. Oct. 21, 2010. 32 pages.
Metal Powder Industries Federation, Porous Metal Design Guidebook, 2007, 24 pages total. Downloaded from the Internet: <<http://www.mpif.org/DesignCenter/porous.pdf>>.
Miller, DP, et al., Thermophysical Properties of Trehalose and Its Concentrated Aqueous Solutions,Pharmaceutical Research, vol. 14, No. 5, 1997, pp. 578-590.
Millipore. "Filter Integrity Test Methods." Millipore Corporation. 1999. 12 pages.
Molokhia et al., "Transscleral iontophoretic and intravitreal delivery of a macromolecule: Study of ocular distribution in vivo and postmortem with MRI", Experimental Eye Research 88 (2009) 418-425.
Moritera, T., et al., "Microspheres of Biodegradable Polymers as a Drug-Delivery System in the Vitreous", Investigative Ophthalmology & Visual Science 32-6 (1991) pp. 1785-1790.
Mott Corporation, "Sintered Metal Powder Media," American Filtration & Separation Society 2007, 2 pages total. Downloaded from the Internet:<<http://www.afssociety.org/education/0907oneminute.htm>>.
Navarro, "The Optical Design of the Human Eye: a Critical Review," J Optom, Jan.-Mar. 2009 2(1): 3-18.
Nutan, M.T.H. et al. (2010) "General Principles of Suspensions," Chapter 2 in Pharmaceutical Suspensions From Formulation Development to Manufacturing, editors AK Kulshreshtha, et al., Spinger. 29 pages.
Okabe et al., "Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device," Investigative Ophthalmology and Visual Science. 2003;44:2702-2707. Downloaded from the Internet: <<http://www.iovs.org/cgi/reprint/44/6/2702>>.
Rosenfeld, "The Latest Research: Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy," Review of Ophthalmology's Retina Online, Feb. 2006; 2 pages. Retrieved from the Internet: http://www.revophth.com/archive/newsletter/0206_retina.htm.
Saline (medicine). Wikipedia, the free encyclopedia. 2011. Web. Apr. 27, 2012. 4 pages. http://web.archive.org/web/20110205192937/http://en.wikipedia.org/wiki/Saline_(medicine).
Sanborn G.E., et al. (Feb. 1992). "Sustained-Release Ganciclovir Therapy for Treatment of Cytomegalovirus Retinitis, Use of an Intravitreal Device." Arch. Ophthalmol. vol. 110, 188-195.
Sharma, Rajesh K., Anna T. Rogojina, and K.V. Chalam. "Bevacizumab Therapy Normalizes the Pathological Intraocular Environment beyond Neutralizing VEGF." Molecular Vision 16(2010): 2175-2184. Print.
Sheardown and Saltzman, Novel Drug Delivery Systems for Posterior Segment Ocular Disease, Opthalmology: Ocular Angiogenesis: Diseases, Mechanisms and Therapeutics, 2007, pp. 393-408.
Smith et al., "Spectrophotometric determination of pKa values for fluorescein using activity coefficient corrections," WaterSA 2002; 28(4):395-402.
Smith, T.J., et al. (1992). "Intravitreal Sustained-Release Ganciclovir," Arch. Ophthamol. 110, pp. 255-258.
Soheilian et al., "Pilot Study of Intravitreal Injection of Diclofenac for Treatment of Macular Edema of Various Etiologies," Retina, Mar. 2010; 30(3): 509-515.
Stay et al. Computer Simulation of Convective and Diffusive Transport of Controlled-Release Drugs in the vitreous Humor, Pharm Res 2003, 20(1), pp. 96-102.
Susvimo Ordering Guide, Genentech, [post date unknown], [Site seen: Nov. 6, 2023], Seen at URL: https://www.susvimo-hcp.com/content/dam/gene/susvimo-hcp/pdfs/physician-and-staff-ordering-guide.pdf (Year: 2023).*
The invisible needle, TSK, [Post date: Unknown], [Site seen Nov. 15, 2023], Seen at URL: https://www.tsklab.com/ophthalmic-needles/ (Year: 2023).*
Theodossiadis et al., "Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration," Am J Ophthalmol. May 2009;147(5):825-830.
Weiner, A.L., "Chapter 13: Polymeric Drug Delivery Systems for the Eye", Polymeric Site-Specific Pharmacotherapy, pp. 315-346, Edited by A.J. Domb (1994) John Wiley & Sons Ltd.
Williams et al., "Treating Diabetic Macular Edema With Ocular NSAIDs," Retinal Physician, Nov. 2007; retrieved from the Internet Nov. 11, 2007. http://www.retinalphysician.com/article.aspx?article=101096>, 5 pages total.
Wright, P., et al. "Slow-Release Artificial Tear Inserts in the Treatment of Dry Eyes Resulting from the Oculomucocutaneous Syndrome", British Journal of Ophthalmology 67 (1983) pp. 393-397.
Yao et al. (2009). "Prevention of Laser Photocoagulation Induced Choroidal Neovascularization Lesions by Intravitreal Doses of Ranibizumab in Cynomolgus Monkeys," ARVO 2009 abstract D906. 2 pages.

Also Published As

Publication numberPublication date
JP1739057S (en)2023-03-15
TWD227104S (en)2023-08-11
CA229753S (en)2024-04-25
TWD227106S (en)2023-08-11
JP1747388S (en)2023-06-27
TWD227103S (en)2023-08-11
JP1747385S (en)2023-06-27
CA229751S (en)2024-04-23
TWD226850S (en)2023-08-01
TWD227102S (en)2023-08-11
JP1747386S (en)2023-06-27
CA229752S (en)2024-04-23
CA214446S (en)2024-07-31
TWD227105S (en)2023-08-11
TWD226875S (en)2023-08-11
JP1747368S (en)2023-06-27
JP1751600S (en)2023-08-24
JP1747387S (en)2023-06-27
CA229754S (en)2024-04-29

Similar Documents

PublicationPublication DateTitle
USD952242S1 (en)Vaporizer device
USD979093S1 (en)Reagent cartridge
USD1033637S1 (en)Fluid exchange device
USD1005517S1 (en)Sample cartridge
USD981349S1 (en)Enclosure
USD912551S1 (en)Timer
USD937917S1 (en)Controlling apparatus for soldering
USD970036S1 (en)Reagent cartridge
USD937916S1 (en)Controlling apparatus for soldering
USD937915S1 (en)Controlling apparatus for soldering
USD1010061S1 (en)Mosquito-repellent device
USD1021084S1 (en)Bellows device
USD1067462S1 (en)Microplate
USD966365S1 (en)Controlling apparatus for soldering
USD980953S1 (en)Faucet
USD1012866S1 (en)Temperature control device
USD989758S1 (en)Operating device
USD1053997S1 (en)Fluid coupling
USD986415S1 (en)Speculum
USD937918S1 (en)Controlling apparatus for soldering
USD1024021S1 (en)Controller
USD1018621S1 (en)Robotic device
USD982137S1 (en)Flow controller
USD972720S1 (en)Port for aspiration device
USD978674S1 (en)Container

[8]ページ先頭

©2009-2025 Movatter.jp